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ABSTRACT 
 
Yi Liu: Fate of Contaminants of Emerging Environmental Concern (CEECs) During 
Drinking Water Treatment Processes 
(Under the direction of Howard S. Weinberg) 
 
Many new chemicals, designed to improve quality of life, and their metabolites 
are released into the aquatic environment through many pathways and become 
contaminants of emerging environmental concern (CEECs).  Six CEECs (atorvastatin, 
caffeine, fluoxetine, iohexol, tetracycline and tetrabromobisphenol A), selected for their 
diverse structure and high use, were evaluated at bench scale for removal from water 
during coagulation and use of powdered activated carbon (PAC), while chlorination and 
ultraviolet treatment were evaluated for byproduct formation.  Although coagulation was 
found to be ineffective, PAC was effective and is recommended for removing CEECs 
from drinking water before disinfection.  Chlorination and UV byproduct structures are 
proposed from infusion-based tandem mass spectrometry results.  Tetracycline was 
studied in more detail and chlorination byproducts included chloroform.  A kinetic study 
evaluating chloroform and total organic halogen formation from chlorination of 
tetracycline at two different pH (7 and 9) revealed elevated levels for both at pH 7.    
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1. INTRODUCTION 
 
 
Advancement in the science and technology industries has produced thousands of 
anthropogenic chemicals to enhance the quality of life.  These chemicals have contributed 
to the increase of agriculture productivity, human lifespan and improvement of human and 
animal health.  Along with the increase in production, use, and disposal of these chemicals, 
much public attention has been directed to their persistence in the environment.  Research 
has shown that there are many pathways for these chemicals to enter the environment but 
many of which can be prevented.  With the improvement in sensitivity and specificity of 
instrumentation and separation methods, detection of many of these chemicals in the 
aqueous and terrestrial environments has improved in recent years (Halden 2010).  
However, the lack of scientific support for the effects of these chemicals and various other 
reasons has led to a slow development of regulations.  Drinking water is one area of 
concern, since the release of these chemicals into surface waters either from wastewater or 
runoff has resulted in their detection in drinking water sources.  Some studies have shown 
that some chemicals are attenuated during conventional drinking water treatment (Benotti 
et al., 2009; Stackelberg et al., 2007; Vieno et al., 2007; Westerhoff et al., 2005) while 
others suggest their transformation into forms which are not targeted by analytical methods 
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(Xu et al. 2012; Duirk et al. 2011; Lam et al. 2005; Vanderford et al. 2008; Eriksson et al. 
2004; Bedner & MacCrehan 2006a; Bedner & MacCrehan 2006b).  If such chemicals, 
their metabolites or transformation products are present in drinking water, chronic daily 
consumption might pose human health concerns and draw attention to how best to reduce 
such exposure. Clearly, the subject of fate and transport of chemicals of anthropogenic 
origin in natural waters and their effects on human and ecological health is still in its 
infancy and much remains unknown. 
 
 
1.1 Contaminants of Emerging Environmental Concern (CEECs) 
 
Chemicals (mostly organic) of anthropogenic origin that are found in natural water 
are referred to in the literature by several names including 'emerging chemicals of 
concern', 'micro-constituents', 'contaminants of emerging concern', 'persistent organic 
pollutants (POPs)', ‘biologically active compounds (BACs)’ 'unregulated contaminants', 
'contaminants of concern', 'pharmaceuticals and personal care products (PPCPs)' or 
'contaminants of emerging environmental concern' (CEECs).   CEECs include PPCPs, 
natural and synthetic hormones, pesticides, perfluorinated compounds (PFCs), phthalate 
plasticizers, surfactants, brominated fire retardants, and other persistent and toxic 
organohalogen compounds (Halden 2010; Bhandari 2008).  Within each category, 
CEECs can be separated into even smaller sub groups.   
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1.2 Pathway of Entry into Drinking Water 
 
 CEECs originate from many different applications such as manufacturing, 
individual consumption, medical practice, veterinary practice, and agricultural 
applications and can be released into the environment including drinking water sources 
through many pathways (Figure 1.1).  Human use of different commercial products in 
daily routines results in solid and liquid waste containing these CEECs which are directed 
to wastewater treatment plants (WWTP) or landfills.  For example, PPCPs are released 
into WWTPs through excretion from humans, which can be in the forms of a metabolite 
or the parent compound, or the disposal of it directly into toilets.  Wastewater treatment 
does not guarantee the complete removal of the chemicals nor do landfills maintain an 
absolute seal over their lifetime (Schwarzbauer et al. 2002) resulting in the release of 
CEECs into water bodies (Heidler et al. 2006; Kolpin et al. 2002).  BACs in the form of 
drugs administered to humans and animals are incompletely metabolized (Hirsch et al. 
1999) but the parent compound and metabolite will be excreted into wastewater 
(Langford & Thomas 2011).  Land applied chemicals such as herbicides and pesticides 
or even the biosolids from wastewater treatment can runoff into rivers and streams (Ritter 
et al. 2011).  These are some of the pathways that lead to the deposition of CEECs in the 
environment (Figure 1.1).  Table 1.1 lists some of the results of a survey of streams in 
the US for 95 organic wastewater contaminants including BACs, hormones, flame 
retardants, etc. all of which are considered CEECs (Kolpin et al. 2002).  The frequent 
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occurrence of some CEECs in this survey raises concerns especially since some of these 
waters are the drinking water sources of many cities.  A median lethal concentration  
(LC50) is the exposure dose of chemical to a living cell (species) in which half of the cells  
die and is used to compare the toxicity of chemicals.  The lower the LC50, the more toxic 
a substance is.  The indicator species referred to in Table 1.1 differed according to the 
chemical tested so as to measure the LC50 for the most sensitive cells.  Some CEECs 
have LC50 values in the μg/L or ng/L range which are the occurrence levels in some 
surface waters and could pose a threat to human health.  
 
Table 1.1: Occurrence, concentration and toxicity of commonly found CEECs in 139 US 
streams (Kolpin et al. 2002). 
Chemical N 
Frequency 
(%) 
Max 
Concentration 
(μg/L) 
LC50 for most 
sensitive 
indicator 
species (μg/L) 
Fluoxetine 84 <1 1.2 N/A 
Caffeine 85 70.6 5.7 40000 
Bisphenol A 85 41.2 12 3800 
Ethanol, 2-butoxy-phosphate 85 45.9 6.7 10400 
4-nonylphenol 85 50.6 40 130 
Triclosan 85 57.6 2.3 4680 
Tri(2-chloroethyl)phosphate 85 57.6 0.54 66000 
Cholesterol 70 84.3 60 N/A 
Coprostanol 70 85.7 150 N/A 
LC50: median lethal concentration 
N: number of samples 
N/A: not available 
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Figure 1.1: Pathways of PPCPs into drinking water and the environment (Bhandari 2008).         
 
Fluorinated organic chemicals (FOCs) are one of the most recently identified 
emerging groups of CEECs and are found in refrigerants, aerosols, non-stick cookware, 
lubricants, aviation, and pharmaceuticals.  Ritter (2012) stated that "3 out of 10 best 
selling drugs in 2011 contain fluorine" and "7 out of 35 new drugs approved in 2011 
contain fluoride".  FOCs have a carbon-fluorine bond, one of the strongest bonds, which 
is difficult to break down.  There are only a few natural degradation pathways for FOCs, 
so it is inevitable that their occurrence is widespread in the environment.  FOCs are 
characterized as persistent organic pollutants (POPs), which are organic substances that 
are able to bioaccumulate, transport long distances, pose potential risk to humans and 
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animals, and are persistent in the environment (Ritter et al. 2011).  FOCs have been 
detected in the air at land and sea all over the Atlantic and Southern Oceans, even in the 
polar regions (Dreyer et al. 2009), and in many animals (Tomy et al. 2009; Holmström & 
Berger 2008; Tao et al. 2006).  FOCs are known carcinogens, endocrine disrupters, and 
liver toxicants and cause developmental and reproductive problems (Maras et al. 2006; 
Martin et al. 2007; Abbott et al. 2007; Lau et al. 2003).  FOCs include 
chlorofluorocarbons (CFCs), which have ozone depletion potential (Molina & Rowland 
1974).  It is important to understand whether FOCs along with other CEECs detected in 
drinking water sources can be eliminated by natural or conventional treatment processes 
or require new treatment processes to remove them.   
 
 
1.3 Fate of CEECs in the Environment 
 
After being released into the aquatic environment, CEECs can volatilize, adsorb 
onto sediment or remain in water, but they can also degrade, react with other chemicals, 
or be consumed by organisms.  Figure 1.2 shows the possible pathways for CEECs after 
their release into the environment.  Chemical structure and properties can help predict 
their fate.  Among them, octanol-water distribution coefficient (Kow) and acidity 
constant(s) (pKa) are very relevant to a wide range of CEECs. 
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Figure 1.2: Fate of CEECs in the environment.   
 
Log Kow describes the affinity of a compound for the organic (octanol) or aqueous 
(water) phase when both are present and can assist in predicting whether a chemical will 
migrate out of water or attach to soil or sediments over which natural water flows.  The 
higher the Log Kow, the more likely a compound is to attach or adsorb onto soil and 
sediment.   Brominated flame retardants have high log Kow values and are, therefore, 
likely to adsorb onto soil and sediment (De Wit 2002), and be available for 
biodegradation or uptake by plants.  For example, tetrabromobisphenol A (TBBPA) and 
polybrominated diphenyl ethers (PBDEs) are found at levels 5500 fold higher in the 
sediment phase compared to the water phase (Labadie et al. 2010).  The same reasoning 
can be applied to CEECs with low log Kow values such as bupropion (anti-depressant, log 
Kow = 1.54) which is found in water but not in sediment (Schultz et al. 2010). 
The pKa of a compound indicates its speciation in water based on the pH.  The 
compound is protonated when the pH is lower than the pKa and deprotonated when the 
pH is higher than the pKa.  In the protonated state, CEECs can be neutral and prefer to 
be in a more neutral organic phase.  When deprotonated and charged, the chemical will 
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prefer the aqueous phase.  Natural waters usually have a pH in the 6-8 range and 
therefore, compounds such as fluoxetine, iohexol, and TBBPA with a pKa higher than this 
will be in the protonated state and exist as a neutral species while compounds such as 
atorvastatin with a pKa lower than the aqueous pH will be in the deprotonated state and 
exist as a charged species.  In summary, the two highlighted physiochemical properties 
suggest that CEECs with high log Kow and pKa values will be more likely to sorb onto 
soils and sediment and be removed during wastewater treatment while those with low 
values are more likely to persist in the aquatic environment (Löffler et al. 2005).  Table 
1.2 shows the values of log Kow and pKa for some CEECs. 
 
Table 1.2: Physical and chemical properties of CEECs. 
Compound 
(Trade Name) 
Category 
Molecular 
Weight 
Log Kow
1 
pKa
2 
Atorvastatin 
(Lipitor®) 
Fluorinated 
pharmaceutical 
558.6 3.76 4.46 
Caffeine Stimulant 194.2 -0.07 6.11 
Fluoxetine 
(Prozac®) 
Fluorinated 
pharmaceutical 
309.3 4.57 10.1 
Iohexol 
X-ray contrast 
agent 
821.1 -3.08 11.4 
TBBPA 
Flame 
retardant 
543.9 5.20 9.40
3
 
Tetracycline Antibiotic 444.4 -1.39 3.30
4
  7.68
4
  9.69
4
 
1
 http://logkow.cisti.nrc.ca/logkow/search.html 
2
(Bhandari 2008) 
3
(Lezotte & Nixon 2001) 
4
(Stephen et al. 1956) 
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Degradation of CEECs in the environment can occur through mechanisms that 
include photodegradation and hydrolysis in water, biodegradation in soil and sediments, 
and reaction with other chemicals in both matrices.   
 
Photodegradation  
Photodegradation can be categorized into two types, direct and indirect photolysis 
(Lam & Mabury 2005).  In direct photodegradation, organic compounds absorbing 
radiation in a sunlit environment become unstable and decompose.  Indirect 
photodegradation involves formation of intermediates such as hydroxyl, carbonate, alkyl 
peroxy radicals, singlet oxygen, aqueous electrons from nitrate and dissolved organic 
matter (DOM) that can then react with organic compounds.  The type of 
photodegradation each CEEC undergoes is different depending on its structure and the 
conditions of exposure.  The byproducts formed can also react with each other, making 
them not well identified, and their effects on human and ecological health are difficult to 
assess.  Eriksson et al. (2004) proposed the major photodegradation byproducts of 
TBBPA and their degradation pathways, one of which was dehalogenation from the 
aromatic ring which is a common process in phenols and their derivatives (Richard & 
Grabner 1999).  
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Hydrolysis 
Hydrolysis is the breakdown of a compound by its reaction with water whose  
rate depends on the compound structure and conditions, such as pH, temperature, ionic 
strength and composition (Mabey & Mill 1978).  Eight pharmaceuticals including 
atorvastatin, caffeine, acetaminophen, carbamazepine, levofloxacin, sertraline, 
sulfamethoxazole, and trimethoprim were determined to not be affected by hydrolysis in a 
controlled experiment (Lam et al. 2004). However, other CEECs such as oxytetracycline 
are affected and pH and temperature were found to have an influence on the rate (Xuan et 
al. 2010).   
 
Biodegradation 
Biodegradation is the breakdown of compounds by microorganisms in the 
environment.  Many of the pharmaceuticals, pesticides, and other CEECs were designed 
to have biological affects and be partially metabolized by their target organisms but in the 
environment they can also be metabolized by other organisms.  In some cases 
compounds are co-metabolized, in which the compound is modified but not used as a 
carbon source (Pérez & Barceló 2007).  Environmental factors such as temperature and 
light intensity can also affect chemical biodegradation as shown by Alexy et al. (2004), 
who assessed 18 antibiotics for biodegradability in a Closed Bottle Test and found that 
not all were readily biodegradable but eliminated through other mechanisms in the 
environment.  In addition, the authors showed that toxicity was not eliminated for any of 
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the antibiotics, indicating potential persistence of non-targeted CEEC degradates in 
surface and possibly drinking water with a lingering biological activity.   
 
 
1.4 Analytical Methods 
 
The accurate determination of CEEC concentration is important for evaluating 
their presence in the environment and whether or not they are of concern to human and 
environmental health.  With a wide range of physical and chemical properties, methods 
developed for CEECs are aimed at clusters such as those with similar polarities but 
different masses.  The mass of a compound and its daughter ions can be determined 
through tandem mass spectrometry (MS/MS), which is the most commonly used 
detection technique for CEECs in the environment.  Since each chemical has different 
daughter ions due to the difference in their structures, MS/MS is very useful in 
identifying the compound of interest.  Usually, separation of chemicals in a mixture 
based on their different physiochemical characteristics proceeds analysis on MS/MS 
through the use of liquid or gas chromatography (LC or GC).  Due to the high boiling 
points of most CEECs, LC-MS/MS is more widely used. 
Due to their low levels in environmental samples, it is essential to concentrate the 
analytes and clean up the extracts because matrix effects can alter the response of a 
compound.  For water samples, the most commonly used isolation technique is solid 
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phase extraction (SPE), where a solid phase is first conditioned with solvent, a large 
volume of pretreated water sample is passed and then the target compound eluted with 
solvent.  The choice of solid phase depends on the analytes of interest.  For capturing a 
broad range of compounds, a hydrophilic lipophilic balanced (HLB) or C-18 solid phase 
is often used with an eluting solvent of methanol and methyl tert-butylether (MtBE) 
(Westerhoff et al. 2005; Vanderford & Snyder 2006; Lee et al. 2009).  While the 
stationary phase is selective for certain chemicals, any compound with the same 
characteristics will also be retained and interfere with the recovery of the target 
compounds.  Once isolated into an organic solvent, the extract can be analyzed by LC- 
or GC-MS/MS with a high level of specificity.  Westerhoff et al. (2005) evaluated 62 
different PPCPs and endocrine disrupting compounds (EDCs) during simulated drinking 
water treatment using SPE paired with LC-MS/MS or GC-MS/MS.  As the 
environmental levels of  new CEECs are considered, existing analytical approaches can 
be adapted for their identification, although full quality controlled methods often lag 
behind the creation and production of many new anthropogenic chemicals.  Since 
occurrence data depend on method development, there is little information for many 
CEEC and more study to update methods is required. 
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1.5 Occurrence in Aquatic Environments 
 
Occurrences of many CEECs in natural water, wastewater sources, and effluents 
have been reported in many studies (Barclay et al. 2012; Halden 2010; Kaplan 2011; 
Kormos et al. 2011; Labadie et al. 2010; Langford & Thomas 2009; Lee et al. 2009; Pérez 
& Barceló 2007; Schultz et al. 2010) (Table 1.3).  These pollutants are present often at 
close to or below detection limits of the existing analytical methods, yet low level chronic 
exposure effects on human  and ecological health are not very well understood.  These 
gaps in our knowledge raise concerns over the fate of CEECs in drinking water treatment 
and whether they would be present in finished drinking water.   
In order to obtain data on occurrence, methods have to be developed and tested for 
environmental samples.  A method for analyzing TBBPA and bisphenol A (BPA) was 
developed by Zhao et al. (2010) using purified water and then tested with real 
environmental samples.  The environmental samples tested were tap water and 
wastewater from Jinan, China.  The method used bamboo-activated charcoal for SPE 
extraction and had a recovery of 80.5-119.8% with a limit of detection of 0.01-0.02ng/L.  
TBBPA and BPA were both detected in the wastewater, but below the detection limit in 
tap water.  
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Table 1.3: Occurrence of CEECs in environmental matrices. 
Compound Name Sample Media Concentration Reference 
Atorvastatin 
(Lipitor®) 
WWTP influent 22-263ng/L 
(Lee et al. 2009) 
WWTP effluent 10-122ng/L 
Drinking water 
source 
0.80-1.4ng/L (Benotti et al. 
2009)  
Drinking water ND 
Fluoxetine  
(Prozac®) 
River water 1.6-43.2ng/L 
(Schultz et al. 
2010) 
Sediment 0.39-19.37ng/g 
Fish brains 0.293-1.648ng/g 
Caffeine 
WWTP influent 54-120μg/L (Stackelberg et al. 
2007) WWTP effluent 0-50ng/L 
Drinking water 0.015μg/L 
(Yang et al. 2011) 
Streams 0-0.19μg/L 
Iohexol 
WWTP influent 3.3-20μg/L 
(Kormos et al. 
2011) 
WWTP effluent 1.1-1.3μg/L 
River water 13-69ng/L 
Drinking water 0-5ng/L 
Riverbank wells >3ng/L 
Tetracycline 
Stream 0-0.11μg/L 
(Kolpin et al. 
2002) 
WWTP primary 
effluent 
68-310ng/L (Yang et al. 2011) 
 
WWTP effluent <10ng/L 
Tetrabromobisphenol 
A 
River water 0-64pg/L (Labadie et al. 
2010) Sediment 65-28 pg/g 
Wastewater 0.013-0.03 μg/L 
(Zhao et al. 2010) 
Drinking water >0.01-0.02μg/L 
ND=Not detected 
 
Benotti et al. (2009) evaluated the occurrence of a total of 51 chemicals, including 
twenty pharmaceuticals, twenty-five EDCs, and six other wastewater contaminants in the 
source water, finished water and water from distribution systems of 19 DWTPs in the US 
between 2006 and 2007.  These DWTPs received a wide range of source waters 
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including groundwater, water bodies with or without input from WWTPs and water 
bodies that allow or do not allow recreational activity.  Out of the 51 chemicals, 34 were 
detected at least once, while 11 were detected more than half of the time. Every DWTP 
source water sample had at least one compound detected.  Source waters that did not 
have WWTP or recreational use input recorded the lowest number of compounds detected.  
This survey demonstrated that a well-protected drinking water source had a lower 
occurrence of CEECs.   
Yang et al. (2011) evaluated a wastewater reclamation plant in Gwinnett County, 
GA.  This WWTP train includes a primary clarifier, aeration tanks, secondary clarifier, 
membrane filtration or granular media filter, granulated activated carbon (GAC) filter, 
and ozone contactor.  Wastewater effluent was collected and analyzed for 19 
pharmaceuticals for twelve months.  Samples were also collected after unit treatments of 
primary clarifier (primary effluent), membrane filtration (membrane effluent), and GAC 
adsorption (GAC effluent).  Caffeine was one of the CEECs found at the highest 
concentrations in the primary effluent (80,000ng/L) and was also found frequently in the 
final effluent (0-50ng/L).   Tetracycline was found in the primary effluent at 160ng/L, 
but was below the detection limit of 10ng/L after microfiltration.  This study showed 
that wastewater treatment is not always effective in removing all CEECs and some will be 
discharged into the aquatic environment. 
Other than occurrence data, water cycles are evaluated to determine where 
pollutants accumulate and what forms they transform into.  The urban water cycle 
16 
 
(WWTP to surface water to ground water and drinking water) was evaluated  for 4 
iodinated x-ray contrast media (ICM) and 46 biotransformation products of these ICMs 
(Kormos et al. 2011).  Samples were taken from WWTPs after different unit processes, 
the discharge river or river wells, and 4 at different points within DWTPs.  There was an 
80% ICM removal for conventional wastewater treatment but transformation products 
were detected in wastewater effluent, river water, river wells, and drinking water.   The 
incomplete mass balance analysis of the ICMs and their transformation products suggests 
that there are many unidentified transformation products unaccounted for by the 
analytical methods employed.   
 
 
1.6 Fate of CEECs in Drinking Water Treatment  
 
There is a reduction in concentration of targeted CEECs from source water to 
finished water in drinking water treatment (Table 1.3), but this decrease is not in 
accordance with the conservation of mass.  Since many studies use methods that are 
very specific to target compounds, untargeted transformation products and metabolites 
will not be detected.  A reduction in concentration of a chemical after a particular 
treatment does not elucidate whether the decrease is due to transformation or removal.  
Studies have shown that some chemicals undergo transformation through photolysis, 
hydrolysis, biodegradation and chemical reaction (Halden 2010), which make tracking of 
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chemicals during treatment difficult and often result in incomplete mass balances.  
Photolysis, hydrolysis and biodegradation were discussed in Section 1.3.  Chemical 
reaction will be discussed later in this chapter.  The transformation products are not well 
understood in either their structure or biological activity.  Although some byproducts of 
a few CEECs such as acetaminophen and iohexol have been identified (Bedner & 
MacCrehan 2006b; Duirk et al. 2011), many remain unknown.  Some of these 
byproducts have potential toxicity higher than the parent compounds.  Therefore, the 
processes of drinking water treatment need to be investigated not only for the removal of 
the parent chemicals but following each chemical treatment process, the byproducts need 
to be identified together with their toxicity. 
 
 
1.6.1 Chemical Coagulation 
 
Chemical coagulation aids in the removal of particulate contaminants and some 
dissolved contaminants including suspended solids, colloids, microbes and natural 
organic matter (NOM).   Aluminum sulfate and ferric sulfate, two of the most 
commonly used chemical coagulants; destabilize particles by neutralizing their charge so 
that they can agglomerate during flocculation.  Coagulant effectiveness is dependent on 
pH because it affects the formation of the hydrolyzed coagulant which assists with 
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precipitation.  Therefore, it is essential to use the optimal pH range for each coagulant 
which is 5.5 – 7.7 (aluminum sulfate) and 5 – 8.5 (ferric sulfate) (Crittenden 2005).  
Chemical coagulation is not very effective in removing trace-levels of organic 
pollutants, with the exception of those with high log Kow value (Westerhoff et al. 2005).  
Such compounds will attach to suspended solids or NOM during coagulation and 
flocculation and be settled or filtered out.  Such is the case with cholesterol (log Kow 
8.74) found at a high concentration (7100μg/kg) in dried settled sludge, whereas 
sulfamethoxazole, acetaminophen, and dehydronifedipine (each with log Kow < 1.0) were 
not detected (Stackelberg et al. 2007).  However, log Kow is not the only predictor of 
CEEC removal which depends also on the pH of the water, concentration of organic 
matter, properties of the water and the functional groups of the CEEC (Choi et al. 2008).  
The pH of the water can change the form of CEEC in the water, as discussed in Section 
1.3, and impact the effectiveness of coagulation on its removal from water.  High 
organic matter concentrations lead to competition with the CEEC and the coagulant.  
Choi et al. (2008) found that the removals of tetracycline antibiotics were different for 
synthetic water and river water, suggesting that the properties of the water are important 
in determining the removal.  Multiple tetracycline antibiotics with similar structures to 
each other were affected differently by coagulation, suggesting that the different 
functional groups play a role in their interaction with coagulants.   
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1.6.2 Powdered Activated Carbon (PAC) 
 
PAC typically used for the removal of taste and odor producing compounds and 
low concentrations of organic micropollutants, including CEECs, can be used at different 
points in drinking water treatment before the filtration process.  Although it can be 
easily added to treatment as a slurry or as dry powder, PAC is costly and, therefore, only 
used when needed.  PAC acts through adsorption of organic pollutants via Van der 
Waals forces.  Addition of PAC during coagulation enhances their removal during 
sedimentation, demonstrated by the increase in removal of tetracycline from ~75% to 100% 
during coagulation when PAC was added prior to filtration (Knappe et al. 2012).  This 
increases the quality of the water before filtration, thereby preserving the filter efficacy 
and lifetime.   
PAC has been shown to greatly remove many CEECs due to its high absorptivity. 
The type of material used in the production of PAC impacts the removal of pollutants.  
The most commonly used are coal based, but others are wood and coconut based.  
Different PACs have different removal efficiencies for CEECs; however, the difference in 
removal between the types of PACs is not as significant compared to the difference in 
removal between different particle sizes of PACs. The smaller the particle size the larger 
the surface area for absorption, which leads to a higher removal of contaminants and a 
shorter time needed for equilibration as demonstrated on tests with sulfamethoxazole and 
trimethoprim (Knappe et al. 2012).    One of the powdered carbons was pulverized into 
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superfine particles resulting in a much higher and more rapid removal of 
sulfamethoxazole (> 60%) and trimethoprim (100%) than when used in its commercially 
available form.   
 
  
1.6.3 Disinfection  
 
Disinfection is often one of the last processes before the treated drinking water is 
distributed to consumers and is designed to kill bacteria and inactivate pathogens.  The 
disinfectant can be added either before filtration to prevent microbial growth in the filter, 
or in the clearwell, or both.  There are three general types of disinfection: heat treatment 
(boiling water), radiation treatment (UV radiation) and chemical treatment (chlorination, 
chloramination, ozone, etc.) (Drinan & Spellman 2013).  Heat treatment is used at the 
point of use when the distribution system is compromised and is, therefore, not 
commonly used in water treatment plants.  Effective disinfectants are required to act in a 
reasonable time, be nontoxic, not be affected by temperature or pH changes and have a 
lasting residual during distribution to prevent microbial growth in the pipes.  The 
disinfectants commonly used can only meet some of these characteristics and are, 
therefore, sometimes used in combination to provide optimal results.  Chlorine is the 
most commonly used disinfectant, but due to its reactions with NOM in the water and 
creation of harmful disinfection byproducts (DBPs) including trihalomethanes (THMs), 
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haloacetic acids (HAAs), and haloacetonitriles (HANs) among others (Duirk et al. 2011; 
Xu et al. 2012; Wang et al. 2011),  chloramination has been used as a replacement 
because lower concentrations are produced (Hua & Reckhow 2007) and the water can be 
in compliance with the current DBP regulations.   
 
Chlorination  
Free chlorine is usually produced from liquid sodium hypochlorite (NaOCl) 
solution, which reacts with water to produce the oxidants OCl
-
 and HOCl (Equation 1 and 
2), with HOCl being the stronger disinfectant species.  A certain contact time is needed 
for effective inactivation or death of pathogens partially due to the chlorine demand of the 
water, which needs to be met before a residual can occur.  Chlorine reacts with ammonia 
to form combined chlorine, which includes mono-, di-, and trichloramine.  This reaction 
has been studied extensively and includes the breakpoint phenomenon in which  for 
every one mole of ammonia as ammonium-N, 1.5 moles of free chlorine as Cl2 is needed 
after which any additional chlorine added is available for disinfection (White 1999).   
                    
            
     
   (pKa = 7.5) 
(Equation 1) 
(Equation 2) 
Chlorination has been shown to be effective in the “removal” of many CEECs or 
at least the parent CEEC molecule is often not found in the chlorine-treated water 
(Westerhoff et al. 2005; Stackelberg et al. 2007; Kaplan 2011; Knappe et al. 2012).  
CEECs can have some of the functional moieties of NOM and are, therefore, likely to 
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produce DBPs upon reaction with chlorine  (Pinkston & Sedlak 2004; Bedner & 
MacCrehan 2006a; Wang et al. 2011; Xu et al. 2012).  Chlorine acts as an electrophile 
and attacks areas on the molecules that are rich in electron density, which include 
aromatic rings with extended π conjugation and found in many CEECs that can act as 
nucleophiles and react with chlorine through electrophilic aromatic substitution. The 
substituents on the benzene ring affect its reactivity through activation or deactivation of 
the ring for electrophilic attack, as well as the position of the electrophile attack on the 
substituted benzene ring (Table 1.4).  Steric hindrance does not usually affect 
electrophilic attacks unless the electrophile is large, in which case attack at the para 
position would be favored over the ortho position, but in the case of chlorine this is not an 
issue.  Steric hindrance of the substituents on the benzene ring does, however, affect 
reactivity.  For example caffeine, which has many substituents on the aromatic ring, will 
not be as reactive as atorvastatin which has few substituents on the aromatic rings. Figure 
1.3 shows a typical electrophilic aromatic substitution with halogen. 
 
Table 1.4: Electrophilic aromatic substitution- effect of substituents (Brown et al. 2005). 
Substituent Reactivity Directing Orientation 
-NH2, -NHR, -NR2, 
-OH, -OR 
Strongly activating Ortho, Para 
-NHCOR, -NHCOAr, 
-OCOR, -OCOAr 
Moderately activating Ortho, Para 
-R, -C6H6 Weakly activating Ortho, Para 
-F, -Cl, -Br, -I Weakly deactivating Ortho, Para 
-COH, -COR, -COOH, 
-COOR, -CONH2, 
-SOOOH, -CN 
Moderately deactivating Meta 
-NO2, -NH3, -CF3, 
-CCl3 
Strongly deactivating Meta 
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Figure 1.3: Generic electrophilic aromatic substitution with halogen (X) as the 
electrophile. 
 
Various chlorination reactions of organic compounds have been studied including 
phenols, dihydroxybenzenes, and amine-containing CEECs (Rebenne et al. 1996; Bedner 
& MacCrehan 2006a; Gallard & Von Gunten 2002).   Chlorination is very reactive with 
phenols since the –OH group is an activating substituent.  Chlorophenols are produced 
causing concerns for water utilities because of the taste and odor these compounds have 
(Burttachell et al. 1959). The end product of the reaction is chloroform, which is a THM, 
but the exact pathway to its formation has not yet been completely elucidated (Gallard & 
Von Gunten 2002).  Chlorination of dihydroxybenzene, which also has –OH substituents, 
produces chlororesorcinol  and dichlororescorcinol (Rebenne et al. 1996).  The position 
at which the chlorine substitution occurs depends on the combined resonance and 
inductive effects of the ring susbtitutents.  Amine-containing CEECs react with chlorine 
to form a product in which chlorine is added onto the amine group.  Fluoxetine, an FOC, 
reacted with chlorine and produced N-chlorofluoxetine with no aromatic substituted 
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product identified (Bedner & MacCrehan 2006a).  The kinetics and reactivity of these 
reactions are pH dependent due to the speciation of free chlorine as HOCl and OCl
-
 
defined by the pKa value and for some CEECs their multiple speciations (e.g. tetracycline 
has 3 pKa values). 
 
Chloramination 
Chloramines, or combined chlorine, are formed from reaction of chlorine with 
ammonia.  Free chlorine reacts with ammonia to form mono-, di-, and trichloroamine 
(Equations 3, 4, 5).  Monochloramine is formed first followed by dichloramine and then 
trichloramine as shown in Equation 3, 4, and 5.  However, because di- and trichloramine 
have a strong odor, their formation is controlled and only monochloramine is desirable as 
a disinfectant.  From breakpoint chlorination chemistry, to limit the formation of 
chloramines to only monochloramine the molar ratio of chlorine to ammonia (as N) needs 
to be 1:1 and the pH of the water needs to be higher than 9.  Compared to free chlorine, 
monochloramine produces lower levels of regulated DBPs, but because it is a relatively 
new disinfectant much less is understood about its interaction with NOM or other 
organics in water, and it may produce more harmful DBPs that are as yet unidentified 
(Hua & Reckhow 2007). 
                   (Equation 3) 
                    (Equation 4) 
                   (Equation 5) 
25 
 
Ultraviolet (UV) Irradiation 
UV irradiation acts through the physical process of damaging DNA so that 
microbes are inactivated (present but not able to cause disease) and unable to reproduce 
(Crittenden 2005).  It cannot be used alone because as a physical process there is no 
residual from treatment and, therefore, no guarantee that microbes will not subsequently 
regrow or otherwise enter the distribution lines.  Usually a chemical disinfectant is used 
after UV treatment to solve this problem.  There are two types of UV lamps used in 
disinfection; low-pressure and medium pressure UV.  Low pressure UV (LP-UV) 
outputs light at 254nm while medium pressure UV (MP-UV) outputs at a range of 
wavelengths between 200 and 400 nm (Lyon 2012).  UV can break down contaminants 
through photolysis and the production of hydroxyl radicals (•OH) that are very reactive, 
similar to photodegradation as explained in Section 1.3.  This can render an otherwise 
inert chemical into a reactive species that can react with the subsequently added chemical 
disinfectant to form DBPs (Lyon 2012).  This exposes parts of the molecule that usually 
do not react with chlorine to do so and form more, and perhaps different, DBPs than 
would otherwise be produced by chlorine alone.    
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1.7 Identification of By-products 
 
The identification of DBPs is very important to accurately assess the risk of their 
potentially harmful environmental and health effects.  It has been shown that DOM in 
the water is a precursor to halogenated DBPs such as THMs, HAAs, HANs and many 
others formed during disinfection with chlorine (Pressman et al. 2010), some of which 
have been shown to be cytotoxic and/or genotoxic (Richardson et al. 2008; Plewa et al. 
2002).  CEECs have similar structural moieties to those found in DOM; therefore, they 
are likely to react with the disinfectant to form chemical byproducts that may harmful to 
humans.  UV disinfection also has been shown to produce many byproducts, which are 
further chlorinated to produce halogenated DBPs (Lyon 2012).  Laboratory studies have 
been simulated for drinking water and wastewater treatment to determine if CEECs are 
transformed or eliminated during chlorination and UV treatment (Vanderford et al. 2008; 
Gould & Richards 1984; Glassmeyer & Shoemaker 2005; Bedner & MacCrehan 2006a; 
Duirk et al. 2011; Wang et al. 2011; Kaplan 2011; Cermola et al. 2006; Lam et al. 2005; 
Pereira et al. 2007; Eriksson et al. 2004; Gomez-Pacheco et al. 2012). 
The analytical instruments that have been used for byproduct identification 
include ultraviolet-visible (UV-Vis) light spectroscopy, MS/MS, nuclear magnetic 
resonance (NMR), and total organic halogen analysis (TOX).  UV-Vis can provide a 
broad scan for byproducts containing chromophores and NMR can help with some 
structural detail, but MS/MS is the best means of product identification if the product can 
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be successfully ionized and fragmented into "fingerprint" daughter ions.  Structures of 
the byproducts can be hypothesized from the information obtained.  Commercially 
available standards can then be used to compare to potential byproducts for confirmation 
purposes. TOX is also a very general method for determining the total amount of 
halogenated organic species in a product mixture and can be used to indicate whether all 
halogenated organic byproducts identified individually by GC and LC methods are 
accounted for.  High pressure liquid chromatography (HPLC) or GC is sometimes paired 
with MS/MS or UV to isolate the byproduct for better sensitivity in detection. However, 
the limitation with these separation techniques is that some byproducts may not elute off 
the chromatographic column.  A summary of some of the literature on CEEC byproducts 
from chlorination and UV treatment is shown in Table 1.5 and Table 1.6, respectively.   
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Table 1.5: Transformation products of CEECs from reaction with free chlorine and their 
identified toxicity activity. 
Compound Reference 
Proposed 
Byproduct 
Analytical 
Instrumentation 
Impact on 
Biochemical 
Activity 
Atorvastatin 
(Vanderford et 
al. 2008) 
Three byproducts 
identified 
QTOF-MS N/A 
Caffeine 
(Glassmeyer & 
Shoemaker 
2005) 
No change observed LC-PB-MS N/A 
(Gould & 
Richards 1984) 
Eight byproducts 
observed, six were 
identified 
GC-MS, TLC, 
UV 
N/A 
Fluoxetine 
(Bedner & 
MacCrehan 
2006a) 
N-Chlorofluoxetine 
formed 
LC-UV-MS, 
LC-UV-EC 
N/A 
Iohexol 
(Duirk et al. 
2011) 
Iodo-THM and 
Iodo-Acids detected 
GC-ECD, 
GC-NCI-MS 
Genotoxic 
and 
cytotoxic 
Tetracycline 
(Wang et al. 
2011) 
Chlorinated and 
hydroxylated 
products without 
substantial ring 
breakage 
LC-(+)-ESI-MS 
activity 
unknown 
(Kaplan 2011) 
Byproducts 
observed but not 
identified 
LC-MS/MS N/A 
QTOF=Quadrupole time-of-flight 
PB=Particle beam 
NCI=Negative chemical ionization 
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Table 1.6: Transformation products of CEECs from reaction with UV treatment and their 
identified toxicity activity. 
Compound Reference 
Proposed 
Byproduct 
Analytical 
Instrumentation 
Impact on 
Biochemical 
Activity 
Atorvastatin 
(Cermola et al. 
2006) 
Five 
byproducts 
identified 
HPLC-UV, 
1
H 
NMR, 
MALDI-MS 
N/A 
Fluoxetine (Lam et al. 2005) 
two 
byproducts 
from direct 
photolysis and 
two 
byproducts 
from indirect 
photolysis 
HPLC-UV, 
LC-MS/MS 
N/A 
Iohexol 
(Pereira et al. 
2007) 
No product 
identified 
HPLC-UV, 
LC-MS/MS 
N/A 
TBBPA 
(Eriksson et al. 
2004) 
Nine 
byproducts 
identified 
1
H NMR, 
HPLC-UV, 
GC-MS 
N/A 
Tetracycline 
(Gomez-Pacheco 
et al. 2012) 
No product 
identified 
Standardized 
biotest 
Byproducts 
generated at 
the beginning 
had higher 
toxicity, then 
decreased 
with longer 
treatment 
time, and 
eventually 
have a lower 
toxicity 
1
H NMR=Proton NMR 
MALDI=Matrix-assisted laser desorption ionization 
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1.8 Policy and Regulation 
 
The Safe Drinking Water Act (SDWA) was created in 1974 to protect public 
health by regulating the public drinking water supply, and was amended in 1986 and 1996 
to include protection of drinking water sources.  The U.S. Environmental Protection 
Agency (U.S. EPA) sets the regulatory limits for contaminants in drinking water under 
the SDWA and the National Primary Drinking Water Regulations (NPDWRs) lists the 
limits for more than 90 contaminants in public drinking water (U.S. EPA 2012a).  The 
contaminants include microorganisms, DBPs, disinfectants, inorganic chemicals, organic 
chemicals, and radionuclides.  The limits enforced are called Maximum Contaminant 
Levels (MCLs) and the recommended limits are called Maximum Contaminant Level 
Goals (MCLGs).  MCLG is the level at which no adverse health effects would be 
observed while the MCL is the highest level of the contaminant that is allowed.  The 
National Secondary Drinking Water Regulations (NSDWRs), also under the SDWA, list 
contaminants that may cause cosmetic or aesthetic effects and are recommended for 
regulations by individual states.   
The SDWA also includes a process that identifies unregulated contaminants that 
may require regulation in the future and periodically publishes a list called the 
Contaminant Candidate List (CCL) (U.S. EPA 2012b).  The CCL helps prioritize the 
contaminants for scientific research and policy making.  CCL 3 is the most current and 
includes 104 chemicals and 12 microbial contaminants.  The contaminants are identified 
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through a three step process by first identifying the universe of potential drinking water 
contaminants, and then applying screening criteria to generate a Preliminary CCL (PCCL), 
which is then further narrowed down to the CCL by detailed evaluation of occurrence and 
health effects through expert judgment.  
In March 2010, the Drinking Water Strategy (DWS) was announced to enhance 
public health protection from contaminants in drinking water (U.S. EPA 2012c).  The 
objective of the program is to “streamline decision-making, expand protection under 
existing laws and promote cost-effective new technologies to meet the needs”.  Four 
goals were identified: 1) address contaminants as groups, 2) encourage development of 
new drinking water technologies, 3) use multiple authority statutes to protect drinking 
water, and 4) develop shared access to monitoring data with states.  The U.S. EPA also 
includes regulations such as the Toxic Substances Control Act (TSCA) passed in 1976 
and the Pollution Prevention Act (PPA) enacted in 1990, which control the production 
and release into the environment of both new and existing chemicals (U.S. EPA 2013).  
Other than U.S. EPA, the Food and Drug Administration (FDA) regulates chemicals in 
consumer goods and the U.S. Geological Survey (USGS) monitors chemicals in the 
environment. 
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1.9 Research Question 
 
The lack of regulation for most CEECs in drinking water and in the environment 
is a major concern for the public.  In order to determine which CEECs to regulate, there 
is first a need to identify if the CEEC occurs in the environment and drinking water, then 
determine if existing treatment processes eliminate the CEEC or creates byproducts, and, 
finally, determine what risk their presence in the environment (and for the purpose of this 
study specifically in drinking water) might have on ecological and human health.  In this 
study, the second of the above steps was investigated for drinking water treatment.  The 
occurrence of many CEECs has already been determined but their fate in the drinking 
water treatment process is not very clear, especially with regards to the formation of 
byproducts from disinfection treatments.  The chemicals that were evaluated in this 
study include three prescription drugs, a stimulant, an X-ray contrast agent, and a 
brominated flame retardant, each of which have been consistently found in wastewater 
effluents, which in turn can become a downstream community's drinking water source.  
Figure 1.4 shows the structures of the CEECs that were selected for this study. 
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Figure 1.4: Structures of CEECs selected for this study. 
 
 
1.10 Research Objectives 
 
The objectives of this study were to: 
1. determine the effectiveness of removal of a set of CEECs through coagulation and 
PAC treatment, 
34 
 
2. identify byproducts of disinfection from chlorination and UV treatment of the 
target CEECs, and 
3. study in more detail the effects of chlorination on tetracycline through by-product 
identification and kinetics.  
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2. MATERIALS AND METHODS 
 
 
2.1 Materials 
 
CEEC Standards 
Atorvastatin calcium salt trihydrate (≥98%), fluoxetine hydroxide, tetracycline 
(≥98%), and 97% 3,3’,5,5’-tetrabromobisphenol A (TBBPA) were purchased from 
Sigma-Aldrich (St. Louis, MO).  Anhydrous caffeine (≥99%) was purchased from Fluka 
Analyticals (Buchs, Switzerland).  Caffeine-d3 (≥99.8 atom % D) was purchased from 
C/D/N Isotopes (Pointe-Claire, QC, Canada).  Iohexol (388.3mg iohexol/mL) was 
obtained from UNC hospitals, where it was sourced from Amersham Health (Princeton, 
NJ).  Simeton (100μg/mL) in methanol was purchased from AccuStandard (New Haven, 
CT).  High performance liquid chromatography (HPLC) grade methanol was purchased 
from Fisher Scientific (Pittsburgh, PA).   
 
Water Used  
Laboratory grade water (LGW) was prepared at the University of North Carolina 
Chapel Hill (UNC) laboratory using a point of use (POU) Dracor Water Systems 
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(Durham, NC) water purification system.  For the POU system, tap water was 
pre-filtered to 1μm, removed of residual disinfectants, total organic carbon (TOC) was 
reduced to less than 0.2mg C/L with an activated carbon resin, and ions removed to less 
than 18MΩ with a mixed bed ion-exchange resin.  Surface water samples from Cane 
Creek Reservoir (Orange County, NC), one of the water sources for Chapel Hill and 
Carrboro, NC, were collected from Orange Water and Sewage Authority (OWASA) 
drinking water treatment plant (Carrboro, NC).  
 
Glassware Preparation 
All non-volumetric glassware was completely emerged in detergent for 24 hours, 
washed with LGW, soaked in 10% nitric acid bath for 24 hours, rinsed with LGW, and 
dried in an oven at 180
o
C.   For volumetric glassware, the same treatment was used but 
without oven drying.  Instead, the glassware was rinsed with certified American 
Chemical Society (ACS) grade methanol (Fisher, Fair Lawn, NJ) and air dried covered 
under kimwipes (Kimberly-Clark, Roswell, GA). 
 
Coagulation  
Coagulant aluminum sulfate n-hydrate (n aproximate12-14), technical grade, was 
purchased from Fisher Scientific (Pittsburgh, PA) and ferric sulfate penta-hydrate was 
purchased from MP Biomedical (Solon, OH).  0.1N sodium hydroxide solution was 
made from sodium hydroxide pellets purchased from Macron Chemicals (Phillipsburg, 
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NJ).  ACS plus grade concentrated sulfuric acid purchased from Fisher Scientific 
(Pittsburgh, PA) was used to prepare 0.2N sulfuric acid. 
 
Powdered Activated Carbon (PAC) 
Coal-based Calgon WPH 1000 (Pittsburgh, PA) PAC was obtained from OWASA.  
The particle diameter of the PAC was <0.150mm (99%) and the pore size was 17.2-17.5Ǻ.  
The 0.7μm glass microfibre filters (934-AHTM) used for filtering samples were purchased 
from Whatman International Ltd. (Buckinghamshire, England). 
 
Chlorination and Chloramination 
Sodium hypochlorite (NaOCl) stock solution as 5.65-6% Cl2 in water was 
purchased from Fisher Scientific (Waltham, MA) and the concentration measured 
monthly using the Iodometric Titration 1 Procedure from Standard Method 408 A 
(American Public Health Association. 1985).  Ammonium chloride, ACS grade, was 
purchased from Mallinckrodt (St. Louis, MO).  Sodium hydroxide, 50% w/w certified 
was purchased from Fisher Scientific (Pittsburgh, PA).  ColorpHast non bleeding pH 
indicator strips (pH 5-10) were purchased from EMD (Gibbstown, NJ).  Chlorine and 
chloramine residuals were measured using a HACH test kit pocket colorimeter and 
HACH permachem N,N-Diethyl-p-phenylenediamine (DPD) free/total chlorine reagents 
(Loveland, CO).  Excess chlorine and chloramines were quenched with analytical 
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reagent (AR) grade anhydrous sodium sulfite (98.9%) purchased from Mallinckrodt 
(Phillipsburg, NJ) or L-ascorbic acid purchased from Sigma-Aldrich (St. Louis, MO).   
 
Ultraviolet (UV)  
Uridine used for actinometry measurements during UV treatment, was purchased 
from Sigma-Aldrich (St. Louis, MO), while disodium phosphate heptahydrate and sodium 
phosphate dibasic hepta-hydrate for the phosphate buffer were purchased from Fisher 
Scientific (Pittsburgh, PA).   
 
Total Organic Halogen (TOX) Analysis 
Glacial acetic acid (99.8% certified ACS grade), ACS plus grade concentrated 
sulfuric acid, potassium nitrate (certified ACS grade), and purified silver acetate used for 
TOX analysis were all purchased from Fisher Scientific (Pittsburgh, PA).  Sodium 
chloride (~80%) for cell performance checks was purchased from Fluka Analytical 
(Buchs, Switzerland).  The method performance check standard, 2,4,6-trichlorophenol 
(98%), was purchased from Sigma-Aldrich (St. Louis, MO).  ColorpHast non bleeding 
pH indicator strips (pH 0-2.5) were purchased from EMD (Gisbbston, NJ).  AR grade 
anhydrous sodium sulfite (98.9%) purchased from Mallinckrodt (Phillipsburg, NJ) was 
used for quenching chlorine residual.  Glass-packed activated carbon columns (2mm 
I.D.) were purchased from CPI international (Santa Rosa, CA).  United States 
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Pharmacopeial (USP) approved oxygen and ultra high purity (UHP) helium were 
purchased as compressed gases from National Welders Supply, Inc. (Morrisville, NC).   
 
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Analysis 
HPLC grade methanol, OmniSolve methyl-t-butyl ether (MtBE), HPLC grade 
acetonitrile, and glacial acetic acid (99.8% certified ACS grade) were purchased from 
Fisher Scientific (Pittsburgh, PA).  Formic acid (99.9%) was purchased from Acros 
Organics (Geel, Belgium).  Ammonium acetate was purchased from Mallinckrodt 
(Phillipsburg, NJ).  Polypropylene glycol (PPG) tuning solution was purchased from 
Varian, Inc. (Santa Clara, CA).  High pressure liquid nitrogen (99.99%), zero grade air 
and UHP argon were purchased as compressed gas from National Welders Supply, Inc. 
(Morrisville, NC).  Nylon membrane filters (0.45 μm) used to filter mobile phase 
solutions were purchased from Whatman International Ltd. (Maidstone, England). 
 
Gas Chromatography Analysis 
Solvents OmniSolve MtBE and HPLC grade hexane were purchased from Fisher 
Scientific (Pittsburgh, PA).  Two standards of chloroform purchased from Supelco 
(Bellefonte, PA) were used in this study; a 5000mg/L standard for confirmation of 
presence and a newer 1000mg standard for calibration.  Hexachlorobenzene, used as an 
instrument performance check standard, was also purchased from Supelco (Bellefonte, 
PA).  Internal standard 1,2-dibromopropane was purchased from Sigma-Aldrich (St. 
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Louis, MO).  UHP helium, UHP nitrogen and medical grade carbon dioxide were 
purchased as compressed gases from National Welders Supply, Inc. (Morrisville, NC).   
 
Dissolved Organic Carbon (DOC) Analysis 
The DOC calibration standard, potassium hydrogen phthalate, was purchased 
from Sigma-Aldrich (St. Louis, MO).  Concentrated hydrochloric acid (certified ACS 
plus) for pH adjustment was purchased from Fisher Scientific (Pittsburgh, PA).  Nylon 
membrane filters (0.45 μm) used for filtering samples were purchased from Whatman 
International Ltd. (Maidstone, England).  Zero grade air was purchased from National 
Welders Supply, Inc. (Morrisville, NC).   
 
Solid Phase Extraction (SPE)  
Waters (Milford, MA) Oasis hydrophilic-lipophilic balance (HLB) 3 cc (60mg) 
SPE cartridges (Lot: W3156J4) were used for SPE.  OmniSolve MtBE and HPLC grade 
methanol were purchased from Fisher Scientific (Pittsburgh, PA).  
Ethylenediaminetetraacetic acid, disodium trihydrate (Na2EDTA 99%+) was purchased 
from Sigma-Aldrich (St. Louis, MO).  Formic acid (98%) was purchased from Acros 
Organics (Geel, Belgium).  UHP nitrogen was purchased from National Welders Supply, 
Inc. (Morrisville, NC).   
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2.2 Methods 
 
 
2.2.1 Solid Phase Extraction 
 
Solid phase extraction (SPE) was used to concentrate aqueous samples for 
analysis by LC-MS/MS.  Neat CEEC stock standards were prepared at 1000mg/L in 
HPLC grade methanol.  For CEECs in powdered form, standards were prepared by 
dissolving 10mg of the target CEEC in 10mL of HPLC methanol in volumetric flasks.  
For CEECs in liquid form, standards were prepared by calculating the volume of CEEC 
needed to be dissolved into 10mL of HPLC methanol in volumetric flasks from the  
given density.  Stock standards were stored in the freezer (-20
o
C) and used within six 
months of preparation.  Table 2.1 shows the concentration of a typical stock solution 
concentration and its dilution used for the experiments.  A mixture of the 6 CEECs (1
○
 
dilution) was prepared at 20mg/L by spiking 200μL of each stock solution into 10mL of 
HPLC grade methanol (Table 2.1).  This solution was also stored in the freezer for use 
within six months.  At different stages of the research, either caffeine or its deuterated 
analogue were available but only one of them was used at a time in the stock solution and 
its subsequent dilutions.  The secondary (2
○
) dilution was prepared at a concentration of 
~0.5mg/L by spiking 250μL of the primary (1○) CEEC mixture in 10mL of LGW.  The 
2
○
 dilution was used to create a standard addition calibration curve for quantifying the 
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CEECs in samples, which were prepared in 250mL aliquots.  The concentration of the 
six CEECs used in the standard addition calibration curve is shown in Table 2.2, and are 
added to each sample right before the addition of Na2EDTA. 
 
Table 2.1: An example of CEEC solution concentrations used in this study. 
CEEC Stock (mg/L) 
1
○
 dilution 
(mg/L) 
2
○
 dilution 
(mg/L) 
Atorvastatin 970 19.4 0.485 
Fluoxetine 1030 20.6 0.515 
Caffeine-d3* 1069 21.4 0.535 
Caffeine* 1093 21.9 0.548 
Iohexol 1000 20.0 0.500 
Tetracycline 1074 21.5 0.538 
Tetrabromobisphenol A 1026 20.5 0.513 
*Only one of these was present in each batch of stock solution and subsequent dilutions, 
 
Table 2.2: Typical CEEC concentrations used for standard addition quantification. 
CEEC 
Cal 1 
(ng/L) 
Cal 2 
(ng/L) 
Cal 3 
(ng/L) 
Cal 4 
(ng/L) 
Atorvastatin 48.5 243 679 1067 
Fluoxetine 51.5 258 721 1133 
Caffeine-d3* 53.5 267 748 1176 
Caffeine* 54.8 274 767 1207 
Iohexol 50.0 250 700 1100 
Tetracycline 53.8 269 753 1184 
Tetrabromobisphenol A 51.3 256 718 1129 
*Only one of these was present in each batch of stock solution and subsequent dilutions, 
 
All standards and extracting solutions used for SPE were prepared the day of or 
day before the extraction including 0.25g/L Na2EDTA stock solution in LGW and 1/9 
(v/v) HPLC grade methanol/MtBE, which was prepared ahead of time by mixing HPLC 
grade methanol and MtBE at a 1 to 9 volume ratio and then filtered through a 0.45μm 
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nylon filter.  The internal standard, simeton, was prepared and stored in the freezer at 
1.25mg/L in HPLC grade methanol.  The aqueous samples were filtered and adjusted to 
a pH of ~2 with formic acid.  Immediately before extraction, Na2EDTA was added at a 
concentration of 1mg/L to chelate the metal ions in the samples and prevent them from 
binding to the active sites on the solid phase cartridge which would otherwise lower 
analyte retention and recovery.  
Extraction of the CEEC analytes used a Supelco Visiprep (Bellefonte, PA) 
extraction manifold.  The Waters Oasis HLB 3cc SPE cartridges were preconditioned 
with 5mL of MtBE followed by 5mL of HPLC grade methanol and then 5mL of reagent 
water.  Reagent water is the sample medium, such as tap water, LGW, or raw water.  
The sample containers were then connected to the SPE cartridges using teflon tubing and 
the samples extracted at a flow rate of 5mL/min.  After rinsing the sample bottles, lines 
and cartridges with reagent water, the cartridges were dried under vacuum (15-18 Hg) for 
30 minutes to remove excess water.  Sample elution was performed using 5mL of HPLC 
grade methanol followed by 5mL of 1:9 HPLC grade methanol/MtBE.  The extract was 
collected in 15mL clear glass conical vials and then concentrated under UHP nitrogen 
using a Pierce (Rockford, IL) Reacti-Vap Model 18770 to a volume of about 200μL.  
Extracts were brought to a final volume of 250μL using HPLC grade methanol.  10μL of 
internal standard simeton in HPLC grade methanol was then added to the extract using a 
10μL glass syringe to produce a final concentration of 50μg/L.  The sample extracts 
were then vortexed using a Thermolyne type 16700 mixer (Dubuque, IA) to ensure 
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complete mixing of the internal standard.  Sample extracts were stored in the freezer at 
-20
o
C for no more than 7 days before analysis. 
 
 
2.2.2 Analytical Methods  
 
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) 
The LC-MS/MS instrumentation consists of a Varian 210 ProStar Solvent 
Delivery Module (Walnut Creek, CA) with a Metachem Technologies, Inc. Degassit Unit 
(Torrance, CA), a Varian 430 ProStar Autosampler (Walnut Creek, CA) and a Varian 
1200L Triple Quandrupole Mass Spectrometer (Palo Alto, CA) with electro spray 
ionization (ESI) or atmospheric pressure chemical ionization (APCI) chamber.  The 
CEECs were separated by a Varian Pursuit C-18 guard (3cm X 2mm, 3μm) and analytical 
(15cm x 2mm, 3μm) column (Walnut Creek, CA).  There were two mobile phases; 
mobile phase A contained 0.1% (v/v) acetic acid and 0.2% (w/v) ammonium acetate in 
LGW while mobile phase B was 100% HPLC grade methanol.  Both were filtered to 
0.45μm prior to use and stored in 1L glass bottles.  For separation of the CEECs, the 
mobile phase was programmed according to Table 2.3.   
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Table 2.3: Mobile phase program used for LC-(+/-)-ESI-MS/MS (flow rate: 0.2mL/min) 
Time % Mobile Phase A % Mobile Phase B 
0 min 90 10 
30 sec 90 10 
35 sec 50 50 
8 min 0 100 
20 min 0 100 
21 min 90 10 
26 min 90 10 
 
The MS/MS settings for each target CEEC were optimized by infusing a 1 mg/L 
solution in 11/9 (v/v) MtBE/methanol, which is the extract solution ratio from SPE without 
blow down (Vanderford & Snyder 2006), of each CEEC individually at a flow rate of 
20μL/min delivered by a Harvard Apparatus Syringe Pump (Holliston, MA).  The target 
CEECs were analyzed in two different ionization modes; positive (+) ESI and negative (-) 
ESI.  The different ion modes used different ionization gases; (+) ESI used UHP argon 
while (-) ESI used zero grade air.  The parameters for the MS/MS are listed in Table 2.4.  
The drying and nebulizing gas was high pressure liquid nitrogen (99.99%).  The collision 
energy for second quadruple (Q2) varied from 0 to 50 eV.  The daughter ion intensity was 
plotted as a function of the collision voltage on the MS/MS breakdown curves recorded by 
the Varian Workstation 6.3 software.   The ionization modes, parent ion, daughter ions, 
retention time, and collision energy of the ions of each CEEC are shown in Table 2.5. 
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Table 2.4: Source dependent mass spectrometer parameters 
Parameter Set Value 
Nebulizer Needle Voltage 5000V 
Shield Voltage 600V 
Detector Voltage (+) ESI:1445V  (-)ESI:1500V 
Drying Gas Flow Rate 18 psi 
Nebulizer Gas Flow Rate 55 psi 
Collision (CID) Gas Flow Rate 2.2 mTorr 
Chamber Temperature 50
○
C 
Drying Gas Temperature 300
○
C 
 
Table 2.5: Parameters for CEEC analysis the study 
 
Ionization 
mode 
Retention 
time 
(min) 
Parent ion 
m/z 
(collision 
energy, (V)) 
Daughter ion 
1 m/z 
(collision 
energy, (V)) 
Daughter ion 
2 m/z 
(collision 
energy, (V)) 
Atorvastatin (+)ESI 7.7 581.4 (5.5) 488.4 (22) 519.5 (26.5) 
Fluoxetine (+)ESI 8.3 310.0 (5.0) 44.1 (5.5) 148.1 (5.0) 
TBBPA (-)ESI 8.0 542.7 (5.5) 417.7 (35.5) 445.7 (28.0) 
Iohexol (+)ESI 7.7 822.0 N/A N/A 
Tetracycline (+)ESI 6.2 445.3 (6.0) 154.0 (18.5) 410.0 (15.0) 
Caffeine-d3 (+)ESI 5.3 198.1 (5.0) 141.0 (11.0) 113.0 (15) 
Caffeine (+)ESI 5.3 195.1 (6.0) 138.0 (13.0) 109.6 (17.5) 
Simeton (+)ESI 8.3 198.1 (5.0) 123.0 (10.0) N/A 
N/A=not available 
 
Dissolved Organic Carbon (DOC)   
DOC analysis used a Shimadzu Corp. TOC-VCPH Total Organic Carbon 
Analyzer with ASI-V Auto Injector.  All water samples were filtered through 0.45μm 
nylon filters as a pretreatment for analysis.  The DOC calibration stock standard was 
potassium hydrogen phthalate at a concentration of 1000mg/L as C which was used 
within two months of preparation.  The DOC working solution was a dilution of the 
DOC stock standard to 100mg/L as C and prepared weekly to create a calibration curve 
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for analysis.  Calibration points were at concentrations of 0, 0.05, 0.5, 5, and 10mg/L as 
C.  Before analysis, pH adjustment to 2 was achieved by addition of 8 drops of 2N 
hydrochloric acid, prepared from concentrated hydrochloric acid, to each 40mL aliquot.  
The samples were then put on the instrument for analysis.  Multiple LGW samples and 
one performance check standard at 5mg/L C were run before the calibration curve, which 
were followed by samples.  After every 10 samples, a performance check standard was 
included in the autosampler sequence.  
 
Total Organic Halogen (TOX) 
A series of treatments are needed before samples are ready for TOX analysis.  
Samples were collected in 125mL amber bottles and if they contained free chlorine were 
quenched with an appropriate amount of sodium sulfite depending on the concentration of 
chlorine residual.  The concentration of quenching agent required was calculated by the  
following equation; 
                                              
The value 3.45 is the molar ratio between chlorine and sodium sulfite multiplied 
by a safety factor of 2 to ensure complete quenching.  Samples were stored 
headspace-free at 4
o
C for no more than 14 days were brought to room temperature right 
before analysis.  Samples were pH adjusted to 2 (approximately 1 drop of concentrated 
sulfuric acid was added to each 125mL sample) and checked with pH paper to ensure that 
all the organic analytes are in the protonated form for better absorption onto carbon.  A 
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volume of the sample was then absorbed onto a carbon column using a 
Tekmar-Dohrmann AD-2000 Adsorption Module (Cincinnati, OH) at a flow rate of 
2mL/min followed by a 2mL nitrate rinse (1.13g KNO3/L as N) at 1mL/min to remove 
adsorbed inorganic halogen ions.  The carbon columns were wrapped in aluminum foil if 
not immediately injected onto the Rosemount Dohrmann DX-2000 Organic Halide 
Analyzer (Cincinnati, OH) but not held for more than 6 hours.  The volume of sample 
absorbed onto the column was determined by estimating the total amount of organic 
halogen in μg of the sample so that it would fall into linear range of the detection for the 
instrument.  Nitrate rinse blanks, which were samples of LGW of the same volume as 
the sample and taken through the nitrate rinse on a clean carbon column, were run at the 
beginning and end of adsorption as a background control for each batch of samples. 
The Organic Halide Analyzer was used to analyze the carbon columns.  The 
instrument used oxygen for combustion and UHP helium as a carrier gas.  The scrubber 
vial was attached as the instrument was started up and detached when all sample analyses 
were complete.  The scrubber vial was filled with 80% (v/v) sulfuric acid.  The 
coulometric cell was conditioned as needed with acetic acid and silver acetate.  The 
furnace temperature was set at 850
o
C.  A cell check was carried out before sample 
injection by spiking 5μL of 200ngCl/μL NaCl solution into the cell; 90-110% recovery 
was required to proceed with the next step, a combustion check in which 5μL of 
500ng/μL of  2,4,6-trichlorophenol in HPLC methanol was spiked on top of a dry carbon 
column.  90-110% recovery was required to proceed with sample analysis.  
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Gas Chromatography (GC) 
The Hewlett Packard 5890 GC with an electron capture detector (ECD), a Hewlett 
Packard GC/SFC 7673 Injector, and Hewlett Packard 7673 Controller were used to search 
for and quantify volatile halogenated byproducts.  The separation column was a 
Phenomenex (Torrance, CA) ZB 1MS (30m x 0.25mm I.D. x 1.0μm Film Thickness).  
The temperature program is shown in Table 2.6.  The injector temperature was set at 
250
o
C and sample injection (splitless-split) volume was 1μL.  The temperature of the 
detector was set at 300
o
C.  A hexachlorobenzene (HCB) solution in hexane at 100μg/L 
was run at the beginning and end of a set of samples as a performance check for the 
instrument.  The carrier gas was UHP helium at a flow rate of 1mL/min.   
 
Table 2.6: Temperature program for GC-ECD 
Time Temperature (
o
C) 
0 min 35 
10 min 35 
36.5 min 300 
40 min 300 
 
The GC paired with mass spectrometry (MS) used a Varian Saturn 2200 ion trap 
with the Varian CP-3800 Gas Chromatograph to identify volatile byproducts from the 
reaction of disinfectants with CEECs.  The separation column used was a Phenomenex 
ZB 5MS (30m x 0.25mm I.D. x 0.25μm Film Thickness).  The temperature program was 
that shown in Table 2.6.  The filament was turned on 3.25 minutes after sample injection 
to avoid solvent front overload.  The injector temperature was set at 250
o
C and a sample 
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extract volume of 1μL was injected manually.  Before the first sample injection, an 
air/water check was carried out to ensure that there was no leak in the system.  HCB in 
hexane (100μg/L) was used as a performance check before any sample run and to ensure 
instrument sensitivity by comparing the area and height of the peak to those obtained in 
previous runs.  The detector was set to scan the mass range of 70-150 Daltons in positive 
ionization mode.  The carrier gas was UHP helium at a flow rate of 1mL/min.   
 
Ultraviolet-Visible (UV-Vis) Analysis 
UV-Vis characterization of samples was undertaken using a Hitachi U-3300 
Spectrophotometer (Danbury, CT).  The solutions and standards prepared at 10mg/L in 
LGW were scanned from 200-700nm to determine the wavelength of maximum 
absorption (λmax). 
 
Medium Pressure (MP) UV System 
The bench-scale MP-UV system was used to stimulate the UV treatment process 
in water treatment plants.  The samples were treated in a custom built unit (Figure 2.1) 
with a 500W MP-UV lamp (Ace-Hanovia, Vineland, NJ).  The sample was contained in 
a 100mL Pyrex crystallization dish with a copper coil around it connected to a Coolflow 
CFT-33 refrigerated recirculator (NESLAB Instruments, Inc. Newington, NH) set at 18
o
C 
to keep the sample at a constant temperature during treatment and stirred constantly.  A 
manual shutter was used to start and stop the UV treatment.  Before using the MP-UV 
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system to treat any samples, the irradiance of the lamp was evaluated with actinometry 
using  a 0.012mM uridine solution prepared from dilution of 1mL of uridine stock 
(12mM) and 10mL of phosphate buffer (100mM at pH 7) into 1 L of LGW, which can be 
used for six months stored at 4
○
C.  The uridine solution was brought to room 
temperature before irradiating.  The volume of the uridine solution irradiated should be 
the same volume as the amount of sample that is treated.  The uridine solution was 
irradiated for a set period of time (x minutes) after the MP-UV lamp has warmed up for 
30 minutes.  A sample of untreated uridine solution was set aside for actinometry 
calculations (designated as t=0).  The t=0 and irradiated samples (designated as t=x) 
were analyzed using a Hitachi U-3300 Spectrophotometer (Danbury, CT) from 
200-400nm.  Along with the uridine samples, the samples prepared to be UV treated 
were also analyzed with the spectrophotometer for their absorbance in this range.  The 
time for irradiation was then calculated based on these absorbance values to achieve the 
required UV dose (mJ/cm
2) using the “MP UV dose calculation” spreadsheet (Lyon 2012).  
The samples were then irradiated for the calculated period of time.  The uridine 
actinometric test was carried out at the end of one day’s batch of samples if the lamp has 
operated for more than 12 hours.   
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Figure 2.1: Diagram of the MP-UV system. 
 
 
2.2.3 Bench Scale Coagulation Experiment 
 
Raw water samples were collected from OWASA (Carrboro, NC), which has two 
sources of water, University Lake and Cane Creek Reservoir (Orange County, NC).  The 
utility uses a combination of two waters as the source for treatment.  On the day of 
collection the utility used a mix of 85% Cane Creek with 15% University Lake water, 
which had a pH of 6.55 and turbidity of 1.09NTU.  The raw water samples used in this 
study were collected from Cane Creek Reservoir and had a DOC concentration of 
2.93mg/L as C, pH of 5.6 and a turbidity of 1.52NTU.  The water samples were 
collected in one 2.5L and seven 4L amber glass bottles.  Samples were transported 
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immediately to the environmental chemistry laboratory in the Michael Hooker Research 
Center at UNC and immediately placed in a refrigerator at 4
○
C and used within two 
weeks of collection.  
Preliminary jar test experiments determined the optimum dose of coagulants and 
amount of pH adjustment needed; all jar tests used the Phipps & Bird Inc. (Richmond, 
VA) Laboratory Stirrer (110 Volts AC).  The coagulants were aluminum sulfate and 
ferric sulfate and prepared as stock solutions in LGW at 7500mg/L as aluminum sulfate 
hydrate and ferric sulfate hydrate.  The OWASA raw water was combined and mixed in 
a 20L glass container with a magnetic stirrer for uniform water quality.  The raw water 
was then separated into two 2L rectangular pyrex jars by measuring out 1.5L of the raw 
water with a graduated cylinder.  The pH of the raw water was tested as the coagulants 
were added to the water while mixing by increments (Table 2.7) of coagulant 
concentration.  Concentrations for aluminum sulfate were 20, 30, 40, 60 mg/L and 40, 
50, 60, 70, 80 mg/L for ferric sulfate.  The pH was adjusted for each coagulant 
concentration with either 0.1N sodium hydroxide or 0.2N sulfuric acid to reach the target 
pH of 5.6 and 5.8 (Knappe et al. 2012) for aluminum sulfate and ferric sulfate, 
respectively.  0.1N sodium hydroxide was prepared by dissolving 4g of sodium 
hydroxide pellets in 100mL of LGW then filtered to 0.45μm using nylon filters.  0.2N 
sulfuric acid was prepared by adding 100μL of concentrated sulfuric acid into 100mL of 
LGW in volumetric flasks.   
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Table 2.7: Coagulant concentration and stock added 
Aluminum sulfate 
concentration  
(mg/L) 
mL of aluminum 
sulfate stock 
added to 1.5L 
sample 
Ferric sulfate 
concentration  
(mg/L) 
mL of ferric 
sulfate stock added 
to 1.5L sample 
20 4 40 8 
30 4+2 50 8+2 
40 4+2+2 60 8+2+2 
50 4+2+2+2 70 8+2+2+2 
60 4+2+2+2+2 80 8+2+2+2+2 
 
A second preliminary jar test determined the optimum coagulant concentration 
and settlement time by using various concentrations (aluminum sulfate: 20, 30, 40, 60 
mg/L, ferric sulfate: 40, 50, 60, 70, 80 mg/L) of coagulant added to different jars and the 
corresponding volume of acid or base for pH adjustment needed for each dose was added 
before the coagulant.  The mixing conditions for the jar test were 30 seconds of rapid 
mix at 100 rpm followed by 36 minutes of flocculation at 25 rpm and settlement for 10, 
30, and 60 min.  The turbidity of the water was tested before pH adjustment and after 
coagulation and settlement time to determine conditions for maximum removal of 
turbidity.   
In the experiment to evaluate the effect of coagulation on CEECs, 1 to 2 L aliquots 
of raw OWASA water were spiked with a 1
○ 
dilution mixture of CEECs (Table 2.1) at a 
concentration of 1000ng/L in volumetric flasks.  This 1
○ 
dilution mixture included 
caffeine-d3.  All the spiked samples were then mixed together using a magnetic stirrer in 
a 20L glass container to create a uniform solution.  The sample was then separated into 
six jars by measuring out 1.5L of the raw water with a graduated cylinder.  Four jars 
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were treated with either aluminum sulfate or ferric sulfate according to results from the 
previous experiments.  The treated and untreated samples were then taken through SPE 
and analyzed by LC-MS/MS.  Quality control samples for each coagulant were created 
by spiking 250ng/L of the CEEC mix into coagulated and settled water samples after 
filtering through 0.45μm nylon filter.  A sample of unspiked raw water, spiked raw 
water, aluminum sulfate-treated water, and ferric sulfate-treated water were tested for 
DOC, turbidity, and pH.   
 
 
2.2.4 Bench Scale PAC Experiment 
 
The surface water described in section 2.2.3 was also used in these tests.  The 
raw water was spiked with the 1
○ 
dilution mixture of CEECs (Table 2.1) at a 
concentration of 1000ng/L in 2L and 1L volumetric flasks, which included caffeine in 
place of caffeine-d3.  All the spiked samples were mixed together using a magnetic 
stirrer in a 20L glass container.  Two aliquots of the spiked raw water were withdrawn 
into 250mL amber bottles as controls and filtered through 1.5μm glass micofibre filters.  
Three PAC doses of 5, 10 and 20 mg/L were tested and each mixed in a 4L amber bottle 
using a magnetic stirrer and Cimarec 2 stir plate (Mastead/Themolyne, Dubuque, IA).  
To prepare the PAC, it was oven dried at 180
o
C to constant weight for about 24 hours and 
each PAC dose was weighed out and added to samples with a few drops of LGW.  
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250mL samples were pulled out after mix times of 2, 5, 10, 15, 30, 60 and 120 minutes 
and were filtered immediately through 1.5μm glass micofibre filters to end the interaction 
between PAC and the water.  For quality control, 250mL aliquots were removed for 
each PAC dose at reaction times of 15 and 60 minutes and 250 ng/L of CEEC mixture 
was spiked in.  Standard addition calibration samples used the 10mg/L PAC dose sample 
pulled after 15 minutes.  The treated and untreated samples were taken through SPE and 
then analyzed by LC-MS/MS.   
 
 
2.2.5 Chlorination and UV Byproduct Identification 
 
Individual CEEC solutions were prepared at 10mg/L in LGW and separated into 
three samples; one for chlorination, one for MP-UV treatment, and one for a control 
sample (untreated sample).  A single MP-UV treatment dose of 1000mJ/cm
2
 was used to 
generate detectable changes.  The chlorination treatment used a chlorine to CEEC molar 
ratio of 20:1 and samples were reacted for 24 hr in the dark under headspace-free 
conditions at 20
○
C in 20mL amber bottles covered with foil.  An example calculation for 
chlorine dose using tetracycline (molecular weight of 444.4) is shown here. 
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After 24 hours reaction, the chlorinated samples were quenched with ascorbic acid 
according to the free chlorine residual concentration.  The ascorbic acid was added as a 
solution in LGW and the amount needed calculated using the equation below; 
                                             
The value 4.96 is the stoichiometric molar ratio between chlorine and ascorbic acid 
multiplied by a safety factor of 2 to ensure complete quenching.  Table 2.8 shows the 
chlorine dose used for each CEEC.  Treated samples and controls were then directly 
infused onto the MS/MS at a flow rate of 20μL/min delivered by a Harvard Apparatus 
(Holliston, MA) Syringe Pump.  Product ions were identified by scanning mass to 
charge (m/z) every 100 Daltons from 50 to 900 Daltons using the same MS conditions 
listed in Table 2.4.  The treated samples were compared to the control sample of 1mg/L 
of CEEC in LGW scanned in the same m/z range.  Ions with significant signal that were 
absent in the control sample were recorded and daughter ions for each product ion were 
identified if they were generated.  From this information, product structure was 
hypothesized. 
 
Table 2.8: Chlorination dose for each 10mg/L CEEC reaction 
Compound Chlorine dose (mg/L) 
Atorvastatin 23.5 
Caffeine-d3 72.7 
Fluoxetine 41.0 
Iohexol 17.3 
Tetracycline 31.9 
TBBPA 26.1 
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2.2.6 Chlorination of Tetracycline Experiment 
 
In a specific case study, the UV-Vis absorbance of the ascorbic acid-quenched, 
chlorine-treated tetracycline (10mg/L) was compared to the untreated sample using a 
Hitachi (Danbury, CT) U-3300 Spectrophotometer.  Another sample of tetracycline was 
prepared at a higher concentration (100mg/L) and reacted with chlorine again at a 20:1 
molar ratio under the same reaction conditions and quenching as described in Section 
2.2.5.  20mL samples aliquots were removed and extracted with 4mL of MtBE.  The 
extracts were analyzed on the GC-ECD and GC-MS for volatile halogenated byproducts.    
A separate kinetic experiment was performed to determine the rate of formation of 
byproducts from 1mg/L tetracycline reacted with 5mg/L chlorine (molar ratio 1:31.3) for 
24 hours at two different pH values (7 and 9) in LGW verified with a Thermo Scientific 
Orion 3 Star pH benchtop pH meter and Accumate pH probe (Cat # 13-620-108A).  
Samples were separated into 125mL and 40mL amber bottles headspace-free and reacted 
separately.  The 125mL samples were used for TOX analysis and the 40mL samples 
were used for GC-ECD analysis.  The samples were chlorinated separately for 10 sec, 20 
sec, 30 sec, 1 min, 2 min, 5 min, 10 min, 20 min, 30 min, 60 min, 2 hrs, 3hrs, and 24 hrs 
and the reaction quenched with sodium sulfite (for TOX) and ascorbic acid (for volatile 
halogenated byproducts).  During longer reactions, samples were placed in the dark, 
headspace-free.  The amount of quenching agent needed was calculated for 5mg/L of 
chlorine and tested beforehand by confirming zero free chlorine when added to different 
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chlorine residuals measured with the HACH (Loveland, CO) test kit pocket colorimeter 
and HACH permachem DPD free chlorine reagents.  The amount of quenching agent 
added was 24.8mg/L for ascorbic acid and 17.7mg/L for sodium sulfite for all samples.  
The concentration of quenching agent required was calculated by the equations described 
previously for ascorbic acid and sodium sulfite.  20mL of the 40mL samples were 
removed from their vials and extracted with 4mL of MtBE spiked with internal standard 
1,2-dibromopropane (100μg/L).  The extracts were analyzed using the GC-ECD method 
described in section 2.2.2.  The 125mL samples were analyzed for TOX using 50mL of 
the sample for absorption onto the carbon columns as described in section 2.2.2. 
 
 
2.2.7 Comparison of Chlorination and Chloramination of Tetracycline 
 
A tetracycline stock solution was prepared at a target concentration of 1000mg/L 
in HPLC grade methanol from which a dilution at 1mg/L in LGW was used for 
chlorination and chloramination at a 20mg/L as Cl2 dose.  Monochloramine solution was 
prepared ahead of time by adding free chlorine drop-wise to 24 mM ammonium chloride 
solution (adjusted to pH 8.5 with sodium hydroxide) at 1.2:1 N:Cl molar ratio (See 
Appendix A for Standard Operating Procedure). The reactions between 1mg/L of 
tetracycline and 20mg/L disinfectant occurred for 24 hr in the dark under headspace free 
conditions at 20
○
C in a 125mL amber bottle covered with foil. The solution was quenched 
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with sodium sulfite after determining the free and total chlorine residual concentration 
with HACH test kit pocket colorimeter and HACH permachem DPD free chlorine 
reagents.  The samples were analyzed for TOX using 50mL of the sample for absorption 
onto the carbon columns as described in section 2.2.2.  
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3. RESULTS AND DISCUSSION 
 
 
3.1 Solid Phase Extraction Recovery (SPE)   
 
The recovery of each target CEEC from SPE or as a result of matrix effects was 
evaluated using LC-MS/MS through parent ion count, area, and relative area (area of 
CEEC/area of internal standard) as described in Section 2.2.1 and 2.2.2.  The samples 
evaluated were a standard at 1mg/L CEEC mixture in 9/11 methanol/MtBE, three 
samples of OWASA raw water (RW) SPE extract spiked at different CEEC 
concentrations (0.25mg/L, 0.5mg/L and 1mg/L), a sample of 1mg/L CEEC mixture 
spiked into raw water before filtration pretreatment (RWB), and a sample of 1mg/L 
CEEC mixture spiked in to raw water after filtration pretreatment (RWA).  Tetracycline, 
which did not fulfill quality control criteria, was not included in the data analysis due to 
poor signal response and high background noise.  None of the targeted CEECs were 
detected in the unspiked raw water.  In order to evaluate whether the detector signal 
response was affected by the raw water matrix, the chromatographic peak areas (Figure 
3.1) and parent ion counts (Figure 3.2) for the 1mg/L standard mix and raw water extract 
spiked with 1mg/L standard mix were compared side by side.  Table 3.1 shows that the 
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signal of caffeine is most impacted by the  raw water extract matrix in both ion count 
and area.  Relative area could not be used for assessment due to the suppressed signal of 
the internal standard, simeton, by the extract matrix.   
 
 
Figure 3.1: Comparison of LC-MS/MS area response for each CEEC in the SPE extract 
(n=1). RW = raw water, RWB = raw water spiked before filtering, RWA = raw water 
spiked after filtering. 
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Figure 3.2: Comparison of LC-MS/MS ion count response for each CEEC in the SPE 
extract (n=1). RW = raw water, RWB = raw water spiked before filtering, RWA = raw 
water spiked after filtering. 
 
Table 3.1: Effect of raw water extract on signal response calculated by area and ion count 
(comparing 1mg/L standard and 1mg/L extract spike).  
 
Caffeine Fluoxetine 
Atorvastati
n 
Iohexol TBBPA 
Raw Water + 1mg/L 
extract spike (area) 
434% 98% 99% 97% 130% 
Raw Water + 1mg/L 
extract spike  (ion 
count) 
491% 102% 127% 100% 130% 
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All CEECs in the RWA sample had a higher signal than in the RWB sample when 
comparing both ion count (Figure 3.2) and area (Figure 3.1), which suggests that the 
CEECs may have been filtered out with the suspended solids in the raw water or have 
adsorbed onto the nylon filter during the pretreatment for SPE.  This is particularly the 
case with TBBPA, which was not detected when spiked into raw water before filtering 
but is fully recovered when spiked into raw water after filtration (Table 3.2).  This could 
be due to the high log Kow of TBBPA, which is 4.50.   
CEEC recovery from SPE was calculated by dividing the response from the RWA 
or RWB samples by that for the 1mg/L CEEC mixture raw water extract spike (Table 3.2).  
The 1mg/L extract spike takes into account the signal enhancement from the raw water 
matrix for more accurate analysis.  Recovery was not analyzed using relative area 
because internal standard was not added to RWA and RWB.  Among the target CEECs, 
caffeine had the highest recovery while iohexol had the lowest.  Comparing analyte 
recovery in the spiked filtered raw water samples, atorvastatin and iohexol had the lower 
recoveries from SPE extraction relative to caffeine and TBBPA, which have recoveries 
higher than 100%.  In general, analyte recovery in spiked filtered raw water samples was 
around the same percentage or a little higher than in the filtered spiked raw water sampled 
for all compounds except TBBPA, which was lost during filtration as already described.  
Since TBBPA is lost during filtration, there would be little difference if standard addition 
for calibration occurs before or after filtration of the samples.  The current method does 
this after filtration and clearly cannot be used for quantifying TBBPA. 
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Table 3.2: SPE recovery of CEECs calculated by area and ion count (comparing RWA or 
RWB and 1mg/L raw water extract spike). RWB = raw water spiked before filtering, 
RWA = raw water spiked after filtering. 
 
Caffeine Fluoxetine Atorvastatin Iohexol TBBPA 
RWB (area) 80% 65% 56% 48% 0% 
RWB (ion 
count) 
87% 70% 53% 52% 0% 
RWA (area) 129% 97% 59% 64% 103% 
RWA (ion 
count) 
154% 96% 46% 60% 108% 
 
A test was then carried out to determine if TBBPA was filtered out by the 0.45μm 
nylon filter or have attached onto the sediment which was filtered out.  A sample of 
TBBPA in LGW was filtered with the nylon filter and analyzed for TBBPA after mixing 
1:1 with HPLC grade methanol through direct infusion mass spectrometry (MS) but 
TBBPA was not detected.  Other types of filters were then evaluated in the same manner.  
The 0.7μm glass-fibre filter was found to be the only one that did not filter out TBBPA, 
and so was used in later experiments in place of the nylon filters but, unfortunately, not 
prior to those described in the next section. 
 
 
3.2 Coagulation for Removal of CEECs from Surface Water 
 
The optimum coagulant dose of alum and ferric sulfate necessary for maximum 
removal of suspended solids in surface water was determined using turbidity 
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measurements before performing the bench scale study involving the CEECs according to 
Section 2.2.3.  The pH was tested and adjusted to 5.6 and 5.8, respectively, for each dose 
as described in Section 2.2.3.  From Figures 3.3 and 3.4 the optimum doses are 50mg/L 
and 70mg/L, respectively, with a settlement time of 60 minutes.  Although doses of 
30mg/L (alum) and 50mg/L (ferric sulfate) could also have been selected, they most 
likely represent the charge neutralization phase (all negatively charged colloids 
neutralized by positively charged coagulants and precipitates).  The selected doses, 
however, are those for sweep flocculation, commonly used in drinking water treatment, 
where contaminants are swept down by the settling flocs.   
 
 
Figure 3.3: OWASA surface water turbidity as a function of varying alum dose after 
different settling times.  
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Figure 3.4: OWASA surface water turbidity as a function of varying ferric sulfate dose 
after different settling times. 
 
Figure 3.5 shows the results of quality control (QC) tests which for each sample 
represents the extracted concentration of the target CEEC in the water to which a 250ng/L 
CEEC mixture spike had been added after sample filtration but prior to SPE.  The 
"before Treatment" QC samples contained 1000ng/L CEEC in the raw water before the 
250ng/L QC mix was added after filtration.  The concentrations shown in figure 3.5 
were obtained from a calibration curve produced for a range of CEEC concentrations in 
the water before filtration so that Figure 3.5 can be used to illustrate CEEC recovery from 
filtration.  For the other samples, a similar recovery can be calculated by comparing the 
results in Figure 3.5 with those in Figure 3.6 which shows the impact of coagulation on 
CEEC removal.  
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Figure 3.5: Comparison of CEEC concentration of quality control samples (250ng/L 
spike). 
 
 
Figure 3.6: Comparison of concentration of CEEC before and after coagulation with alum 
and ferric sulfate. Error bars represent the difference in concentration of duplicate 
samples.  
 
Overall it appears that coagulation with either alum or ferric sulfate had little to no 
effect on the CEECs except in the case of ferric sulfate on atorvastatin.  The latter has a 
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pKa value of 4.46 and thus exists as a negatively charged species in this water permitting 
its charge neutralization or partial bonding with NOM that aids in its removal with the 
flocs.  The data showed two anomalies: (i) iohexol in the "before treatment" QC sample 
suggested a 140% recovery (see Appendix Table B-5) which would then lower the value 
in Figure 3.6 to below the concentration found in the coagulated samples.  This should  
be interpreted as meaning that coagulation had no impact on iohexol; (ii) the ferric 
sulfate-treated tetracycline showed no recovery in the QC sample (i.e. no difference in 
concentration of tetracycline between the unspiked and spiked samples).  The SPE 
method calls for addition of 1mg/L EDTA to chelate residual free cations that may 
otherwise complex charged target ions such as the zwitterion forms of tetracycline in this 
matrix and lead to unpredictable recoveries from SPE.  This amount of EDTA can 
chelate a maximum of 0.19mg/L of ferric ion, a small amount compared to that likely to 
remain in the solution after coagulation and settling.  A further complication will arise 
from any eluted ferric ions in the extract placed on the mass spectrometer which can 
cause signal enhancement -- a likely explanation for the elevated tetracycline signal 
shown in Figure 3.6.  Hence, it is not possible to interpret the results for tetracycline in 
this experiment.  Moreover, Westerhoff et al. (2005) suggest that coagulation removal is 
correlated with log Kow in which chemicals with a higher log Kow value have higher 
removal.  This suggests that tetracycline should not be removed by coagulation.  
Knappe et al. (2012) reported a 74% removal of tetracycline during coagulation with 
ferric sulfate using similar conditions although their raw water DOC concentration was 
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5.2mg/L while in this study the DOC concentration was 2.9mg/L.  The higher DOC may 
have facilitated the removal in the Knappe et al. (2012) study.  Both studies showed 
ineffective removal of caffeine. 
 
 
3.3 CEEC Removal from Surface Water by Powdered Activated Carbon (PAC) 
 
Results for only three of the target CEECs (caffeine, fluoxetine and TBBPA) are 
presented because data for atorvastatin, iohexol and tetracycline did not meet quality 
control criteria.  Figures 3.7 to 3.9 illustrate the kinetics of PAC doses 5mg/L, 10mg/L, 
and 20mg/L, respectively, and Table 3.3 lists the first order kinetic rate of adsorption of 
the CEECs.  At all doses of PAC, CEEC removal is above 70% after 120 minutes of 
contact time; however, at the 5mg/L PAC dose there was an inconsistent trend which may 
be due to the CEECs and NOM adsorbing and desorbing over time causing fluctuation of 
dissolved CEEC concentration.  The kinetic rate of adsorption increases with PAC dose 
except for fluoxetine which has a higher rate at 10mg/L.  In general, caffeine and 
fluoxetine have a higher removal and rate when compared to TBBPA at the 10mg/L PAC 
dose.  The mechanism of PAC adsorption involves the attraction between CEEC and the 
carbon particles through Van der Waals forces or the partitioning of CEEC between the 
liquid (water) and carbon (solid) phase.  The affinity of each CEEC to PAC cannot be 
predicted based on log Kow. At each contact time, the removal of TBBPA (log Kow= 
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8.02) is lower than that of caffeine (log Kow = -0.07) which is the opposite of the 
prediction.  Clearly, other properties impact removal such as molecular size, structure, 
ionic versus neutral form, pH of the water, DOC concentration of water, and type of PAC.   
 
 
Figure 3.7: Removal of CEECs at PAC dose of 5mg/L over time. 
 
 
Figure 3.8: Removal of CEECs at PAC dose of 10mg/L over time. 
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Figure 3.9: Removal of CEECs at PAC dose of 20mg/L over time. 
 
Table 3.3: First order kinetic rate (M L
-1
 s
-1
) of adsorption of CEECs by PAC. 
PAC dose Caffeine Fluoxetine TBBPA 
5mg/L 0.0077 0.0176 0.0057 
10mg/L 0.0297 0.0206 0.0125 
20mg/L 0.0303 0.0187 0.0178 
 
Knappe et al. (2012) evaluated PAC adsorption of pharmaceuticals at different pH 
values, PAC dose, water matrix, and type of PAC.  They found that the pH at which 
neutral forms of pharmaceuticals prevailed was the optimum condition for their removal.  
The pH of the water in this current study was approximately 7, which, based on their pKa 
values (Table 1.2 of Section 1.3), indicates that caffeine, fluoxetine and TBBPA were in 
neutral form, and would have predicted removal which is supported by the results here.  
Knappe et al. (2012) further showed increased adsorption of pharmaceuticals at higher 
PAC doses, which is also the case in this study.   
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Knappe et al. (2012) also evaluated the effect of PAC addition during coagulation 
on pharmaceutical, DOC and turbidity removal.  Their results indicated that while no 
significant increase in DOC and turbidity removal occurred compared to coagulation 
without PAC, there was a significant increase in removal of the pharmaceuticals.  
Taking into account the high removal of CEECs with PAC shown in this current study, its 
use during drinking water treatment would significantly reduce CEEC concentration 
before disinfection and reduce the formation of byproducts resulting from interaction with 
the disinfectant. 
 
 
3.4 Chlorination and UV Treatment Byproducts 
 
3.4.1 Chlorination Byproducts  
Chlorine-treated CEECs quenched with ascorbic acid were directly infused onto 
the MS to scan for individual product ions and compared to those of the untreated sample 
as described in Section 2.2.5.  Table 3.4 lists the parent and daughter ions if they were 
found for each CEEC after chlorination.  A quenched chlorine solution was also infused 
but no ions were observed in the selected mass range.  The reactivity of the CEECs is 
evaluated by the change in signal of the parent ion in the chlorine-treated sample. 
Fluoxetine, caffeine, and iohexol were not as reactive because the parent ions were still 
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very abundant in the treated solution compared to those in the untreated LGW solution 
(Table 3.4), whereas atorvastatin and tetracycline were very reactive.  The reactivity can 
be explained by the substituent effect on electophilic aromatic substitution reactions.  
Atorvastatin and tetracycline contain activating substituents (-NR2 and -OH), whereas 
fluoxetine and iohexol contain deactivating substituents (-CF3 and -I).  TBBPA was not 
detectable in this experiment.  The lack of reactivity with caffeine is likely due to the 
highly substituted aromatic ring sterically hindering the ability of  free chlorine to 
approach the molecule (Kaplan, 2011).  A list of the parent and daughter ions of each 
CEEC in LGW is listed in Table 3.5. 
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Table 3.4: Ions found in the chlorine-treated CEEC solution (* indicates ions that are 
present in the untreated sample, ions in bold may contain chlorine) 
CEEC (m/z, ion 
count, ESI mode 
of parent ion 
before treatment) 
Ionization 
Parent ion 
(approximate 
ion count) 
Daughter ion 
1 m/z (ion 
count) 
Daughter ion 2 
m/z (ion count) 
Atorvastatin 
 (581.4, 1E07, 
(+)ESI) 
+ESI 
80.9 (9E06) ND ND 
82.9 (3E06) ND ND 
215.0 (4E07) ND ND 
247.1 (1E07) 229.0 (5.4E05) 167.0 (6.4E04) 
407.0 (7E06) 214.0 (1.0E06) ND 
476.4 (2E06) ND ND 
597.3 (3E07) 462.3 (1.3E6) 554.3 (3.3E05) 
598.3 (1E07) 554.6 (1.7E05) 462.7 (9.0E04) 
599.3 (3E06) 556.3 (3.1E04) ND 
613.2 (4E06) ND ND 
631.2 (1E07) 308.4 (8.3E04) 458.3 (1.5E04) 
632.2 (3E06) 237.3 (1.7E04) 124.3 (2.5E03) 
633.2 (3E06) ND ND 
634.2 (3E06) ND ND 
-ESI 
60.8 (4E07) ND ND 
76.8 (7E07) ND ND 
ND=Not detected 
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Table 3.4 (continued): Ions found in the chlorine-treated CEEC solution (* indicates ions 
that are present in the untreated sample, ions in bold may contain chlorine) 
CEEC (m/z, ion 
count, ESI mode 
of parent ion 
before treatment) 
Ionization 
Parent ion 
(approximate 
ion count) 
Daughter ion 
1 m/z (ion 
count) 
Daughter ion 2 
m/z (ion count) 
Fluoxetine 
 (310.0, 4E07, 
(+)ESI) 
+ESI 
62.7 (8E06) ND ND 
80.8 (1E07) 79.7 (2.8E05) ND 
82.8 (3E06) ND ND 
90.0 (1E07) 88.9 (7.1E05) 72.6 (1.1E04) 
148.2 (2E07) 102.9 (3.7E05) 69.0 (1.1E05) 
215.0 (1E08) ND ND 
*310.0 (1E08) ND ND 
*360.2 (2E07) 147.9 (8.8E05) 163.9 (7.4E05) 
-ESI 
173.0 (1E07) 120.4 (1.7E03) 75.4 (1.6E03) 
175.2 (3E06) ND ND 
177.0 (1.5E06) ND ND 
193.2 (1E07) ND ND 
206.0 (4E07) ND ND 
208.4 (4E07) ND ND 
209.4 (4E07) 64.2 (2.2E03) 177.7 (1.2E03) 
210.1 (2E07) ND ND 
211.1 (1E07) ND ND 
219.4 (5E07) ND ND 
220.0 (2.5E07) ND ND 
341.1 (5E06) 88.6 (6.4E03) ND 
Caffeine-d3  
(198.1, 6E07, 
(+)ESI) 
+ESI 
80.9 (1E07) ND ND 
86.0 (1E07) 68.7 (1.2E04) ND 
112.9 (2E07) 71.9 (2.0E04) 56.5 (1.1E05) 
141.0 (2E07) 94.7 (9.4E05) 83.1 (5.5E05) 
157.0 (1E07) 110.8 (3.7E05) ND 
171.0 (1E07) 152.3 (7.6E04) 85.8 (2.9E04) 
175.0 (2E07) 62.9 (8.8E05)) 130.8 (1.4E06) 
*198.1 (6E07) ND ND 
215.0 (1E08) ND ND 
-ESI 
*60.8 (7E07) ND ND 
*61.9 (7E07) ND ND 
*76.8 (7E07) ND ND 
173.0 (5E06) ND ND 
219.1 (4E06) 98.8 (1.5E04) 128.6 (1.1E04) 
ND=Not detected 
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Table 3.4 (continued): Ions found in the chlorine-treated CEEC solution (* indicates ions 
that are present in the untreated sample, ions in bold may contain chlorine) 
CEEC (m/z, ion 
count, ESI mode 
of parent ion 
before treatment) 
Ionization 
Parent ion 
(approximate 
ion count) 
Daughter ion 
1 m/z (ion 
count) 
Daughter ion 2 
m/z (ion count) 
Iohexol  
(843.9, 3E06, 
(+)ESI) 
+ESI 
*65.0 (1E07) ND ND 
157.0 (5E06) ND ND 
175.0 (5E06) 130.8 (4.5E05) 62.8 (3.3E05) 
197.0 (4E06) 62.8 (4.3E05) 153.0 (2.6E05) 
*198.1 (3E06) ND ND 
199.0 (1E07) 62.7 (9.7E04) 56.8(3.6E03) 
215.0 (7E07) ND ND 
247.0 (2E07) ND ND 
255.1 (6E06) 156.9 (8.8E05) 144.8 (4.8E05) 
407.0 (1E07) 214.9 (1.7E07) ND 
*843.9 (8E06) ND ND 
-ESI 
*60.9 (4E07) ND ND 
*76.8 (4E07) ND ND 
Tetracycline  
(445.3, 1E07, 
(+)ESI) 
+ESI 
80.8 (2E07) ND ND 
82.9 (6E06) ND ND 
-ESI 
*60.8 (5E07) ND ND 
61.8 (5E07) ND ND 
*76.7 (5E07) ND ND 
ND=Not detected 
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Table 3.5: Ions found in CEEC solution in LGW 
Compound Ionization 
Parent ion 
(approximate ion count) 
Atorvastatin  
+ESI 
559.8 (1E07) 
575.5 (5E06) 
581.2 (1E07) 
-ESI 557.0 (1E08) 
Fluoxetine  +ESI 
149.0 (1E07) 
279.1 (1E06) 
310.2 (4E07) 
360.2 (5E06) 
Caffeine-d3 
+ESI 
198.1 (6E07) 
220.1 (1E07) 
-ESI 
60.8 (2E07) 
65.8 (2E07) 
76.8 (2E07) 
Iohexol  
+ESI 
65.0 (2E07) 
198.1 (1E07) 
822.9 (1E06) 
843.9 (3E06) 
-ESI 
60.8 (3E07 
76.8 (6E07 
Tetracycline  
+ESI 
158.1 (1E07) 
445.1 (1E07) 
-ESI 
59.9 (1E08) 
60.9 (1E08) 
76.8 (1E08) 
 
Chlorine Isotopes 
In order to identify whether the byproducts contain chlorine, the isotope ratios 
between 
35
Cl, 
37
Cl, and 
39
Cl were investigated (Table 3.6).  The ions listed in bold in 
Table 3.4 are those that exhibit the correct isotope ratio for chlorine incorporation and in 
all cases suggest only a single atom of chlorine incorporation.  For example, the ions 
with m/z 80.9/82.9 in the ratio 3:1 are present in atorvastatin, fluoxetine and tetracycline 
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and could be indicative of chloroethanol, a toxic, colorless liquid.  The relative 
proportions of these ions to the parent ion are much lower for fluoxetine (which contains 
no -OH groups) than for tetracycline and atorvastatin both of which contain multiple -OH 
groups giving this observation some credibility. 
 
Table 3.6: Relative intensities (highest ion count set to 100%) of isotopes for up to 3 
chlorine atoms in an ion (Glagovich 2007) 
 Cl 2Cl 3Cl 
(M)
+
 100 100 100 
(M+2)
+
 31 65 95 
(M+4)
+
  10 31 
 
Structure of Byproducts 
Some possible structures based on the mass to charge of ionizable chlorination 
byproducts are shown in Figures 3.10-3.13.  The nitrogen rule (even number of nitrogen  
atoms in an ion = even mass, odd number of nitrogen atoms in an ion = odd mass) was 
used to account for the number of nitrogens in the structure.  For byproducts that contain 
daughter ions, some were also hypothesized (see Appendix B, Table B-1) based on 
Glagovich (2007).  The byproducts confirm the mechanism of electrophilic attack by 
chlorine of the aromatic rings, especially in the case of iohexol which has only one 
aromatic ring that appears to be completely broken apart.  Although the identity of 
chlorine-incorporated byproducts could not be reasonably conjectured, their identification 
would be further confirmation that electrophilic substitution had occurred. 
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The structure of the byproducts can be indicative of bioactivity so that if a major 
part of the parent structure is retained after reaction so could its bioactivity.  Compared 
to the parent structure of atorvastatin (Figure 3.10), the byproducts at m/z 215.0 and 247.1 
do not have much of the original structure intact and the biological activity of these 
byproducts will probably have changed.  This is also the case for all the byproducts 
hypothesized for fluoxetine, caffeine and iohexol.  The byproduct at m/z 407.0 from 
atorvastatin, on the other hand, still contains much of the parent structure and might still 
possess some biological activity.  The loss of parent structure and bioactivity does not 
necessarily suggest that the byproduct is less toxic than the parent compound.  Other 
studies have shown that the byproducts of chlorination have higher toxicity than the 
parent compound (Bedner & MacCrehan 2006b; Duirk et al. 2011; Richardson et al. 
2008). 
 
Figure 3.10: Possible structures of the chlorination byproducts of atorvastatin at m/z, 
a)247.1, b)407.0 and c)215.0. 
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Figure 3.11: Possible structures of the chlorination byproducts of caffeine at m/z, a)141.0, 
b)171.0 and c)86.0. 
 
 
Figure 3.12: Possible structures of the chlorination byproducts of fluoxetine at m/z, 
a)215.0 and b)148.2. 
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Figure 3.13: Possible structures of the chlorination byproducts of iohexol at m/z, a) 407.0, 
b)255.1, and c)175.0. 
 
 
3.4.2 UV Byproducts  
A list of the parent and daughter ion masses found for each CEEC after UV 
treatment according to the experiments described in Section 2.2.5 is presented in Table 
3.7.  Atorvastatin and iohexol were very reactive under UV irradiation, whereas 
fluoxetine, and in particular caffeine and tetracycline, were not.  The degradation of 
chemicals under UV irradiation can occur by direct or indirect photolysis (Section 1.6.3).  
Direct photolysis breaks down the chemical through absorption of the incident 
wavelengths which are in the range 200-400nm in the case of MP-UV.  The structures 
that usually absorb in this range contain delocalized π-electron systems which are found 
in aromatic rings and conjugated double bonds.  Chemicals containing these structures 
83 
 
undergo excitation when irradiated with UV and can either experience structural change 
or energy loss from heat or light emission indicating that there is no simple rule to predict 
reactivity based on chemical structure (Schwarzenbach et al. 2003).  Indirect photolysis 
occurs through the generation of radicals that are extremely reactive but non selective 
with most chemicals.  Hence, the structures of CEECs cannot definitively predict their 
reaction during UV treatment.  The number of byproducts from UV treatment with the 
targeted CEECs is much lower than those identified from chlorination.   
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Table 3.7: Ions found in UV-treated sample CEEC solution (* ions that are present in 
CEEC standard) 
CEEC (m/z, ion 
count, ESI mode 
of parent ion 
before 
treatment) 
Ionization 
Parent ion 
(approximate 
ion count) 
Daughter ion 
1 m/z (ion 
count) 
Daughter ion 
2 m/z (ion 
count) 
Atorvastatin 
(581.4, 1E07, 
(+)ESI) 
+ESI 
56.9 (1E07) ND ND 
438.4 (1E06) ND ND 
513.2 (1E06) 120.0 (3.8E4) 395.1 (2.5E03) 
*559.3 (5E05) ND ND 
595.4 (2E06) ND ND 
-ESI 
60.9 (5E07) ND ND 
65.9 (5E07) ND ND 
76.7 (2.5E07) ND ND 
Fluoxetine 
(310.0, 4E07, 
(+)ESI) 
+ESI 
90.9 (3E07) ND ND 
115.0 (1E07) 88.9 (1.4E07) ND 
117.0 (2E07) 115.0 (6.6E06) ND 
*149.1 (1E07) 117.8 (2.3E6) 115.9 (5.6E5) 
164.1 (1E07) 109.1 (6.3E4) 76.8 (6.0E04) 
166.0 (2E07) 104.9 (1.7E05) 119.2 (4.2E04) 
259.1 (9E06) 230.8 (4.6E05) 90.8 (3.3E05) 
*310.2 (2E07) ND ND 
-ESI 
60.8 (7E06) ND ND 
76.8 (7E06) ND ND 
91.8 (7E06) ND ND 
Caffeine-d3 
(198.1, 6E07, 
(+)ESI) 
+ESI 
86.0 (2E07) ND ND 
113.0 (2E07) 85.8 (6.4E05) 57.5 (4.3E04) 
143.0 (3E07) 58.1 (1.7E06) 97.1 (2.2E05) 
*198.1 (8E07) ND ND 
*220.1 (3E06) ND ND 
-ESI 
*60.8 (1E07) ND ND 
*65.8 (1E07) ND ND 
*76.8 (1E07) ND ND 
196.1 (4.1E06) 98.7 (3.9E03) 152.5 (4.6E03) 
229.4 (7E06) 210.5 (2.4E04) 139.5 (6.1E03) 
ND= Not detectable 
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Table 3.7 (continued): Ions found in UV-treated sample CEEC solution (* ions that are 
present in CEEC standard) 
CEEC (m/z, ion 
count, ESI mode 
of parent ion 
before 
treatment) 
Ionization 
Parent ion 
(approximate 
ion count) 
Daughter ion 
1 m/z (ion 
count) 
Daughter ion 
2 m/z (ion 
count) 
Iohexol 
(843.9, 3E06, 
(+)ESI) 
+ESI 
*65.0 (1E07) ND ND 
91.9 (5E06) ND ND 
149.0 (4E06) 103.1 (4.7E05) 84.8 (1.8E05) 
*198.1 (6E06) ND ND 
-ESI 
*60.9 (5E07) ND ND 
65.9 (5E07) ND ND 
*76.8 (5E07) ND ND 
Tetracycline 
(445.3, 1E07, 
(+)ESI) 
+ESI 
*158.0 (1E07) ND ND 
*445.1 (1E07) ND ND 
-ESI 
*59.9 (1E08) ND ND 
*60.9 (1E08) ND ND 
*76.8 (1E08) ND ND 
ND=Not detectable 
 
Table 3.8 lists the calculated molar absorptivity at the wavelength of maximum 
absorption of targeted CEECs in the UV range for 10mg/L solutions.  The chemicals 
with higher molar absorptivity (e.g. iohexol and atorvastatin) seem to correspond with 
those of highest reactivity in the UV irradiation experiments.  However, tetracycline has 
a high molar absorptivity at 274nm but is not reactive with MP UV irradiation, suggesting 
molar absorptivity is not the sole predictor of reactivity.  Figure 3.14 shows the output of 
the UV MP lamp illustrating a broad spectrum of irradiation. 
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Table 3.8: Molar absorptivity of CEECs (10mg/L) at their λmax .  
CEEC λmax (nm) Molar absorptivity (M
-1
 cm
-1
) 
Atorvastatin 241 17763 
Caffeine 
272 10060 
205 27596 
Fluoxetine 226 11599 
Iohexol 245 33583 
TBBPA 206 6146 
Tetracycline 
274 16176 
362 13732 
 
 
Figure 3.14: Spectrum of lamp output for MP UV. 
 
Structure of Byproducts 
The hypothesized UV byproduct structures are shown in Figures 3.15-3.17 while 
those with daughter ions are described in Appendix B, Table B-2 based on Glagovich 
(2007).  CEECs whose byproducts have the highest masses are most likely to retain 
much of the original structure and perhaps bioactivity.  However, UV disinfection is 
usually not used alone in full-scale treatment and is paired with a chemical disinfectant 
such as chlorine or chloramines in drinking water treatment.  The UV treatment can 
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break down the original CEEC into a smaller molecule which may or may not be reactive 
with chlorine.  Lyon (2012) observed an increase in DBP formation from adding 
chlorine after UV treatment of surface water at high UV doses but not at lower doses.  
However, only the known DBPs were analyzed; therefore, it cannot be certain that low 
UV doses do not generate DBP precursors.  
 
 
Figure 3.15: Hypothesized structures of UV byproducts of atorvastatin at m/z, a) 438.4 
and b) 513.2.  
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Figure 3.16: Hypothesized structures of UV byproducts of fluoxetine at m/z, a) 164.1 and 
b) 259.1. 
 
 
Figure 3.17: Hypothesized structures of UV byproducts of iohexol at m/z, a) 149.0 and b) 
91.9. 
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If chlorine was used as the chemical disinfectant following UV treatment, the UV 
byproducts containing aromatic structures would probably react, forming chlorinated 
byproducts through electrophilic substitution.  This is especially the case with 
atorvastatin which appears to retain most of its parent structure.  The fluoxetine 
byproduct at m/z 259.1 appears to have retained the deactivating –CF3 substituent, 
rendering it less reactive to chlorine.  On the other hand, the byproduct at m/z 166.0 did 
not retain the deactivating substituent and may actually have a weakly activating 
substituent, suggesting it might be more active than fluoxetine towards chlorine.   
 
 
3.5 Tetracycline Case Study 
 
In a separate experiment 1mg/L tetracycline in reaction with 20mg/L as Cl2 free 
chlorine and chloramine was studied in more detail according to Section 2.2.7.  
Reactivity of tetracycline with both disinfectants was high as reflected in the absence of 
the original chemical in the treated sample and a large amount of halogenated byproduct 
measured by TOX.  Since reaction with chlorine produces the highest level of TOX its 
reaction was studied in more depth. 
A solution of tetracycline in LGW and chlorinated tetracycline quenched in LGW 
were analyzed for their UV absorbance spectrum as described in Section 2.2.6.  
Tetracycline has a λmax at 276nm and 356nm (Figure 3.18).  If the reaction with chlorine 
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resulted in the incorporation of chlorine on the benzene rings of tetracycline, the λmax 
should have increased (Robinson et al. 2005).   The quenched chlorinated solution has 
neither of the original peaks but has a λmax at 232nm (Figure 3.19) suggesting that the ring 
structure of the tetracycline may no longer be intact.  Further characterization of the 
sample used direct infusion MS but no product was identified.  In order to identify lower 
molecular weight and perhaps more volatile byproducts another more concentrated 
solution of chlorinated tetracycline was analyzed using GC-ECD after liquid-liquid 
extraction as described in Section 2.2.6 and a product peak was found.  In order to 
identify this product peak (See Appendix B, Figure B-1), the extract was analyzed using 
GC-MS and the mass spectrum of that peak shown in Figure 3.20 is a match for 
chloroform which has previously been identified as a product of oxytetracycline (Xu et al. 
2012).  Since the two chemicals have similar structures they might be expected to have 
similar byproducts.  However, Xu et al. (2012) identified additional reaction products of 
chlorine with oxytetracycline including dichloroacetone, trichloroacetone, 
dichloroacetonitrile, trichloroacetonitrile and trichloronitromethane but these were not 
seen in the chlorination byproducts of tetracycline.  Xu et al. (2012) used 9.2mg/L of 
tetracycline to react with 26.3mg/L of chlorine under varying pH conditions controlled by 
buffer solutions.  Buffer solution was not used in this current study to prevent other 
reactions with chlorine.  Additionally, the concentrations of both tetracycline and 
chlorine in this current study are considerably higher than those in Xu et al. (2012).   
Nonetheless, chloroform is one of the regulated DBPs in drinking water.   
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Figure 3.18: Absorbance spectrum of 10mg/L tetracycline in LGW, with λmax at 276nm 
and 356nm. 
 
 
Figure 3.19: Absorbance spectrum of chlorinated tetracycline (10mg/L tetracycline, 
31.9mg/L chlorine), with λmax at 232nm. 
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Figure 3.20: Spectrum of product peak (chloroform) from GC-MS analysis of chlorinated 
tetracycline. 
 
The kinetics of chloroform and TOX formation from chlorination of tetracycline 
were evaluated at pH 7 and 9 as described in Section 2.2.6.  Figure 3.21 shows the 
distribution of HOCl and OCl
-
 as a function of pH.  At pH 7 HOCl predominates while 
at pH 9 OCl
-
 is the dominant species.  HOCl and OCl
- 
both react though the same 
mechanism of aromatic substitution and oxidation; however, HOCl is the more reactive 
species because it is a stronger oxidant.  OCl
-
 replenishes HOCl when the latter is 
consumed to reestablish equilibrium in the system.  Therefore, when HOCl is more 
abundant the reaction with tetracycline produces more chloroform.  An evaluation of the 
concentration of chloroform formed over time at different pH values shows that at each 
timed point it is higher at pH 7 than at pH 9 (Figure 3.22).  This is also the case for the 
formation of TOX, shown in Figure 3.23, but the impact of pH is larger. 
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Figure 3.21: Distribution of HOCl and OCl
-
 with varying pH. 
 
 
Figure 3.22: Comparison of the formation of chloroform over time by chlorination of 
tetracycline with respect to pH. 
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Figure 3.23: Comparison of the formation of TOX by chlorination of tetracycline over 
time with respect to pH. 
 
Figures 3.24 and 3.25 show the concentration of chloroform and TOX formed in 
μmol/L of chlorine at pH 7 and pH 9, respectively.  At pH 7, 27% of the TOX formed 
was accounted for by chloroform whereas at pH 9 this increased to 50%.   
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Figure 3.24: Comparison of TOX and chloroform formation from chlorination of 
tetracycline at pH 7. 
 
 
Figure 3.25: Comparison of TOX and chloroform formation from chlorination of 
tetracycline at pH 9 
 
The rate of formation of chloroform and TOX could not be calculated from kinetic 
rate equations but linear regressions fitted through different time segments during the 
reaction were used to calculate formation rates at different times (Table 3.9-3.10).  
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Comparing the initial rates of formation, for TOX it is greater than the rate of chloroform 
formation; however, this difference is smaller at pH 7 compared to pH 9.  Also noting 
the difference between rate of formation of chloroform between pH 7 and pH 9, the initial 
rates are very different but then become about the same.  This suggests the initial 
concentration of HOCl available for reaction is the main determinant in how much 
chloroform forms during chlorination of tetracycline.    
The rate of formation of chloroform and TOX decreases rapidly over time.  
There were only two segments for TOX formation because TOX was only analyzed for a 
subset of the times of those analyzed for chloroform.  Comparing the rates for segment 1, 
TOX formation was much faster than chloroform and formation was faster at pH 7 
compared to pH 9.  The formation of chloroform could be occurring through the reaction 
of chlorine with the -OH containing ring in tetracycline.  In Gallard & Von Gunten 
(2002), the formation of THMs from reaction of chlorine with phenol was studied, but no 
reaction mechanism was suggested.   
 
Table 3.9: Rate constants (M
 
sec
-1
) for the formation of chloroform from chlorination of 
tetracycline at pH 7 and 9. 
 Time Rate constant at pH 7 Rate constant at pH 
9 
Segment 1 0 min - 1min 19300 6600 
Segment 2 2 min - 20 min 400 500 
Segment 3 30 min -24hours 8 8 
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Table 3.10: Rate constants (M
 
sec
-1
) for the formation of TOX from chlorination of 
tetracycline at pH 7 and 9. 
 Time Rate constant at pH 7 Rate constant at pH 
9 
Segment 1 0 min - 1min 37200 11100 
Segment 2 1 hour - 24 hour 10 20 
 
In drinking water treatment, if tetracycline was present in the source water, it 
might not be removed through coagulation, depending on the DOC concentration in the 
source water (Section 3.2).  PAC addition can remove tetracycline but if it is not used 
then tetracycline will be present during final disinfection.  The use of UV pre-treatment, 
especially under typical operating doses will not likely breakdown tetracycline (see 
Section 3.4.2), which means that if it is present in source water it would likely generate 
some halogenated byproducts. 
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4. CONCLUSIONS 
 
 
 The effectiveness of bench scale drinking water treatment processes, and in 
particular disinfection with chlorine and UV on the removal of CEECs in surface water 
was evaluated in this thesis.  This addresses the concern of whether current drinking 
water treatment processes can protect finished water from CEEC contamination if such 
chemicals are present in the source water.  It is not possible to evaluate every one of the 
many CEECs in production and use so representative ones in high use found in many 
surface waters and having different structural properties were selected for this study.  
They were atorvastatin (FOC, lipid regulator), caffeine (stimulant), fluoxetine (FOC, 
antidepressant), iohexol (x-ray contrast agent), tetracycline (antibiotic) and TBBPA 
(flame retardant).   The treatment processes evaluated were coagulation with aluminum 
and ferric sulfate, PAC, chlorination and MP-UV and elevated levels of CEECs were 
used compared to environmental concentrations so as to monitor trends with existing 
analytical methods.  SPE was used to isolate the analytes from aquatic matrix, which 
was tested to have recoveries ranging from 64-154%. 
 Coagulation was not particularly effective in removing CEECs as predicted due 
to the high solubility of the selected chemicals.  PAC on the other hand was 
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demonstrated to be highly effective, around 90% at the highest PAC dose (20mg/L), in 
the removal of three of the CEECs, fluoxetine, caffeine and TBBPA.   Chlorination and 
UV irradiation were shown to transform the CEECs into byproducts to varying degrees.  
Atorvastatin and tetracycline were the most reactive to chlorine, while atorvastatin and 
iohexol were the most reactive under UV.  Bioactivity was not measured in this study, 
but if the structures of the byproduct contain the moieties of the parent compound that 
were responsible for its activity then bioactivity may still be present in the treated water. 
 Although this study identified only a few of the byproducts from chlorination 
and UV treatment, albeit under conditions not representative of full-scale treatment, the 
results serve to show that residual CEECs in drinking water sources cannot be ignored. 
While coagulation was not shown to be a reliable and catch-all good barrier, PAC did 
remove a high percentage of all the CEECs evaluated in this study.  If UV were used as 
a pretreatment to break down some of the more recalcitrant chemicals, overall removal 
could be improved.  This study did show that UV can change a relatively inert chemical 
into one that is more reactive with chlorine, and so if activated carbon was not used 
between or before the two treatments, new chlorination byproducts of unknown toxicity 
might persist into consumers’ drinking water.  Since the effects of chronic low level 
human exposure to such chemicals is unknown, it is prudent to provide a dual strategy of 
watershed protection with adjustments to drinking water treatment to ensure consumer 
protection from the unknown yet potential effects of the presence of CEECs in water.  
100 
 
APPENDIX A: SOP FOR MONOCHLORAMINE DOSING SOLUTION 
PREPARATION 
 
Standard Operating Procedure (SOP) for Monochloramine Dosing Solution 
Preparation and Residual Measurement 
 
Prepared by Katja Kritsch edited by Yi Liu 
 
Materials: 
1. Laboratory grade water (LGW), purified using a secondary water purification 
system (Pure Water Solutions, Hillsborough, NC). Water pretreated with an 
general in-house purification system was pre-filtered (1 µm filter), treated to 
remove chlorine or chloramine residuals, passed through an activated carbon resin 
to reduce the total organic carbon content to less than 0.2 µg/L and passed through 
mixed-bed ion exchange resins to reduce the ion content to less than 18 MΩ.   
2. Sodium hypochlorite (Fisher Scientific, Pittsburgh, PA, USA), 5 - 6%, 
concentration determined according to procedure 4500 Cl B. Iodometric Method 
I in Standard Methods for the Examination of Water and Wastewater, 2
0th
 edition
1
 
3. Ammonium sulfate (Fisher Scientific, Pittsburgh, PA, USA), granular, ≥99%, 
certified ACS 
4. Sodium hydroxide (Fisher Scientific, Pittsburgh, PA, USA), 50% w/w/certified 
5. Intermediate range pH test strips, EMD colorpHast (Fisher Scientific, Pittsburgh, 
PA, USA), pH 5 – 10  
 
 
Glassware: 
 All glassware must be washed in detergent (Alconox), rinsed with tap water and 
LGW, soaked in a 10% Nitric acid solution over night, rinsed three times with LGW and 
dried in an 180°C oven designated for glassware drying. Volumetric glassware must be 
rinsed three times with methanol and dried in the fume hood and cannot be place in the 
oven. Caps and Teflon cannot be acid washed. They are washed in a soap bath separate 
from glassware and each other, rinsed three times with tap water, three times with LGW 
and three times with methanol. To dry, caps and liners are placed on a clean Kimwipe, 
covered with another Kimwipe and dried in the fume hood.  
 
 125 mL amber Boston round bottles with open-top caps and Teflon-lined septa for  
(Laboratory Supply Distributors, Mt. Laurel, NJ, USA) 
 10 mL and 100 mL clear glass volumetric flasks with ground glass stoppers for 
stock solution preparation and UV measurement (Pyrex, Corning Inc., Corning, NY, 
USA) 
 250mL Clear Erlenmeyer flask (Pyrex, Corning Inc., Corning, NY, USA);  
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 1 mL and 10 mL glass pipettes (Pyrex, Corning Inc., Corning, NY, USA)  
 Pasteur pipettes  
 Rubber bulbs 
 25mL glass burette (Pyrex, Corning Inc., Corning, NY, USA) for free chlorine 
titration 
 Glass rod for stirring 
 
 
Instruments and Additional Materials: 
 Analytical Balance  
 UV vis spectrometer 
 Quartz cuvettes 
 Kimwipe 
 Lens wipes 
 Burette Stand 
 Stir plate and Teflon-coated stir bar for titration 
 Hexagonal polystyrene weighing dishes 
 
 
Solution Preparation: 
NaOH Solution (1M) for pH adjustment 
1. Fill a 25mL volumetric flask half full with LGW. 
2. Add 1.3mL of 50% w/w NaOH into the volumetric flask. 
3. Fill the volumetric flask to the mark with LGW, stopper and invert three times 
to mix. 
 
24mM Ammonium Sulfate Solution (Stock Solution) 
1. Tare one polystyrene weighing dish on the analytical balance and accurately 
weigh 0.128 g dry ammonium sulfate. 
2. Quantitatively transfer solids into a clean, dry 100 mL volumetric flask. 
3. Use a Pasteur pipette to carefully rinse any solids remaining on the weighing 
dish into the volumetric flask using LGW by slightly tipping the weighing 
dish slightly for the LGW to drain into the volumetric flask. 
4. Carefully rinse any residuals on the funnel into the volumetric flask with 
LGW. 
5. Swirl flask gently until all solids are dissolved. 
6. Fill the volumetric flask to the mark with LGW, stopper and invert three times 
to mix. 
7. Adjust to pH 8 with 1M NaOH (Typically ~5 drops). Test pH with pH paper. 
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Chloramine Dosing Solution Preparation and Analysis: 
Chloramine Dosing Solution Preparation  
1. Transfer ammonium sulfate solution to a 250mL Erlenmeyer flask in an ice 
bath.  
2. After the solution has cooled down, place stir bar in flask and place on stir 
plate to mix solutions lowly. 
3. Determine the volume of hypochlorite stock solution to add to the ammonium 
sulfate solution using the following equation: 
            
                 
              
 
where volume is the amount of hypochlorite stock to add, 1400 mgCl2/L 
is the target stock concentration of the monochloramine solution, 100mL is 
the volume of ammonium sulfate solution, and [Cl2] is the measured 
hypochlorite stock solution in mg/L as Cl2. 
4. Measure out this amount and add to the glass burette. 
5. Open the burette very slowly and add the hypochlorite stock drop-wise to the 
flask. 
6. When all hypochlorite solution is added, transfer the solution to a 125mL 
amber bottle with cap and PTFE-lined septa. Measure the concentration of the 
monochloramine solution following the instruction on the next section. Store 
solution at 4
o
C if not used immediately. 
 
Determination of the Chloramine Concentration in the Dosing Solution  
1. Turn on the UV-Vis instrument at least 30 minutes prior to use to warm up 
the lamps. 
2. Prepare a 1:20 dilution of the dosing solution by transferring 0.5 mL of the 
dosing solution into a 10 mL volumetric flask using a glass pipette and fill to 
the mark with LGW. 
3. Stopper the flask and invert three times to mix. 
4. Zero the instrument with LGW.  
5. Transfer an appropriate volume of diluted dosing solution into the cuvette and 
measure the absorbance at the wavelengths 245 and 295 to determine both the 
monochloramine and dichloramine concentrations by solving simultaneous 
Beer's Law equations, as described by Schreiber and Mitch (2005). 
                 
 
 
 
       
    
      
         
 
                        
      
 
 
 
 
 
  cdi  = concentration dichloramine [mg/L] 
  MCl2= molar mass of Cl2 [g/mol] 
  A245 = total absorbance measured at a wavelength of 245 nm 
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  A295 = total absorbance measured at a wavelength of 295 nm 
  ε di,245 = 208 = extinction coefficient of dichloramine at λ = 245 nm 
  ε di,295 = 267 = extinction coefficient of dichloramine at λ = 295 nm 
  ε m,245 = 445 = extinction coefficient of monochloramine at λ = 245 nm 
  ε m,295 = 14 = extinction coefficient of monochloramine at λ = 295 nm 
                 
    
      
     
       
      
  
  cm  = concentration dichloramine [mg/L] 
6. Use the calculated concentration cm to for dosing calculations. Be sure that the 
results give a low (or sometimes negative due to the error range of the method) 
number for dichloramine if “pure” monochloramine dosing solution is 
desired. 
7. Free chlorine and free ammonia may be determined using the Hach 
colorimeter and the appropriate procedures. However, it is not likely that free 
chlorine or free ammonia is present with a 3:1 chlorine-to-ammonia ratio. A 
dosing solution with a monochloramine concentration close to 1500 mg/L 
indicates that the preparation of pure monochloramine was successful. In case 
that a higher chlorine-to-ammonia ratio is employed it is recommended that 
the free chlorine concentration in the dosing solution is determined. It is also 
likely that a considerable concentration of dichloramine will be present. 
 
 
References: 
American Public Health Association, American Water Works Association, and Water 
Environment Federation, 1999. Standard Methods for the Examination of Water 
and Wastewater. 20th Edition, American Public Health Association: Washington 
DC. 
Schreiber, I.M. & Mitch. W.A., 2005. Influence of the order of reagen addition on 
NDMA formation during chloramination. Environmental Science & Technology, 
39(10). pp.3811-3818. 
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APPENDIX B: SUPPLEMENTARY DATA 
 
Table B-1: LC-MS/MS ion count response for CEECs. RW = raw water, RWB = raw 
water spiked before filtering, RWA = raw water spiked after filtering. 
Compound 
1 mg/L  
standard 
RW  
spiked 
0.25mg/L 
RW  
spiked 
0.5mg/L 
RW  
spiked 
1mg/L 
RWB RWA 
Caffeine 1.57E+06 2.30E+06 4.70E+06 7.72E+06 6.73E+06 1.19E+07 
Fluoxetine 8.67E+07 2.65E+07 4.91E+07 8.82E+07 6.17E+07 8.44E+07 
Atorvastatin 9.45E+05 4.12E+05 6.90E+05 1.20E+06 6.37E+05 5.53E+05 
Iohexol 1.10E+06 3.81E+05 5.28E+05 1.11E+06 5.70E+05 6.61E+05 
TBBPA 1.86E+06 7.59E+05 1.55E+06 2.41E+06 0.00E+00 2.62E+06 
 
Table B-2: LC-MS/MS area response for CEECs. RW = raw water, RWB = raw water 
spiked before filtering, RWA = raw water spiked after filtering. 
Compound 
1 mg/L  
standard 
RW  
spiked 
0.25mg/L 
RW  
spiked 
0.5mg/L 
RW  
spiked 
1mg/L 
RWB RWA 
Caffeine 3.47E+07 5.46E+07 8.60E+07 1.51E+08 1.21E+08 1.94E+08 
Fluoxetine 1.22E+09 3.68E+08 6.48E+08 1.19E+09 7.70E+08 1.16E+09 
Atorvastatin 1.21E+07 4.31E+06 7.40E+06 1.20E+07 6.73E+06 7.08E+06 
Iohexol 1.21E+07 3.04E+06 6.69E+06 1.18E+07 5.65E+06 7.58E+06 
TBBPA 2.04E+07 9.60E+06 1.83E+07 2.75E+07 0.00E+00 2.82E+07 
 
Table B-3: LC-MS/MS relative area response for CEECs. RW = raw water 
Compound 
1 mg/L  
standard 
RW  spiked 
0.25mg/L 
RW  spiked 
0.5mg/L 
RW  spiked 
1mg/L 
Caffeine 10.1 36.3 74.8 145 
Fluoxetine 35 244 563 1150 
Atorvastatin 3.54 2.86 6.44 11.5 
Iohexol 3.53 2.02 5.82 11.3 
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Table B- 4: Turbidity (NTU) of preliminary coagulation experiment 
Dose 
(mg/L) 
Aluminum Sulfate Ferric Sulfate 
Settling time Settling time 
10 min 30 min 60 min 10min 30 min 60 min 
0 1.19 1.05 1.02 1.07 1.1 1 
20 1.2 0.48 0.39 3.71 3.62 3.36 
30 0.99 0.38 0.3 2.81 1.65 1.37 
40 1.19 0.45 0.38 2.05 1.27 1.15 
50 0.66 0.25 0.23 1.9 0.95 0.9 
60 1.04 0.37 0.44 1.64 1.15 1.02 
 
Table B-5: Comparison between quality control samples and samples for coagulation data 
(ng/L). Highlighted samples are outliers. 
 Alum treated Ferric treated Before treatment 
 1 2 QC-250 1 2 QC-250 1 2 QC-250 
Caffeine-d3 1149 684 934 1522 1170 928 912 1199 1155 
Fluoxetine 515 528 498 416 454 266 554 333 841 
Tetracycline 1066 584 547 1421 1279 1096 333 801 837 
Atorvastatin 1579 1698 1161 1188 1267 751 1646 1132 1656 
Iohexol 1558 1739 1500 1447 1508 1153 1945 1422 2634 
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Table B-6: Possible structures for daughter ions of chlorination byproducts. 
Compound Byproduct 
Byproduct daughter 
ion 1 
Byproduct 
daughter ion 2 
Atorvastatin 
 
247.1 
 
229.0 
 
167.0 
 
407.0 
 
214.0 
N/A 
Caffeine d3 
 
86.0 
 
68.7 
N/A 
 
141.0 
 
94.7 
 
83.1 
 
171.0 
152.3 
 
85.8 
N/A= Not available  
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Table B-6 (continued): Possible structures for daughter ions of chlorination byproducts. 
Compound Byproduct 
Byproduct daughter 
ion 1 
Byproduct 
daughter ion 2 
Fluoxetine 
 
148.2 
102.9 69.0 
Iohexol 
 
175.0 
130.8 
 
62.8 
 
255.1 
156.9 144.8 
 
407.0 
214.9 
N/A 
N/A= Not available  
 
 
 
 
 
 
 
108 
 
Table B-7: Possible structures for daughter ions of UV byproducts. 
Compound Byproduct 
Byproduct daughter 
ion 1 
Byproduct 
daughter ion 2 
Atorvastatin 
513.2  120.0 395.1 
Fluoxetine  
164.1 
144.2 109.1 
 
259.1 
 
230.8 
90.8 
Iohexol 
 
149.0 
 
103.1 
 
84.8 
N/A: Not available 
 
109 
 
 
Figure B-1: Comparison of LC-MS/MS relative area response for SPE extraction of 
CEECs. RW = raw water. 
 
 
 
Figure B-2: Chromatographic peak of chlorinated tetracycline on GC-MS. 
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